top of page

Kaoru Fujinami

CONTACT INFORMATION

Business address 1: 2-5-1, Higashigaoka, Meguro-ku, Tokyo, 152-8902, Japan
Phone: (+81) 334110111
Business address 2: Room G4, Wolfson Building, 11-43 Bath St, London EC1V 9EL, UK
Phone: (+44) 2076086850

E-mail address: k.fujinami@ucl.ac.uk

EDUCATION

2013-2016           PhD (Advanced Placement), Retinal Cell Biology Group, Department of Ophthalmology, Keio University School of Medicine, Tokyo, Japan (Title: Investigation of inherited retinal disease).

1998-2004           Nagoya University, School of Medicine, Japan

1995-1998           Tokai high school, Nagoya, Japan

PROFESSIONAL BACKGROUND

National Institute of Sensory Organs, Tokyo, Japan                              
Laboratory of Visual Physiology/Ophthalmic Genetics, Division of Vision Research
Position: Director                                                                2017-present
・Develop novel therapeutic approaches for inherited retinal disease
・Clarify genotype-phenotype correlations for inherited retinal disease
・Elucidate ancestor of inherited retinal disease
・Develop novel protocols for electrophysiological assessment
・Promote extended protocols for electrophysiological assessment
・Apply artificial intelligence for clinical ophthalmology
 
Position: Visiting Principal Investigator                                                    2016-2017
・Establish ABCA4 world-wide cohort to investigate the ethnic variability
・Promote data-sharing system for East Asia Inherited Retinal Disease consortium
・Clarify genotype-phenotype correlations for inherited retinal disease

Position: Investigator    2013-2016
・Develop data-sharing system for Japan Eye Genetics consortium (JEGC)
・Establish clinical diagnostic criteria/analysis pipleline for next generation sequencing for JEGC
・Clarify genotype-phenotype correlations for inherited retinal disease

Position: Visiting Researcher                                                          2009-2013
・Characterise macular dystrophy in a Japanese nation-wide cohort.
・Genotype a Japanese cohort with inherited retinal disease
・Clarify genotype-phenotype correlations for inherited retinal disease


University College London, London, UK                                       
Genetics, Institute of Ophthalmology 

Position: Honorary Professor                                      2020-present
・Establish world-wide cohort of inherited retinal disease to investigate the ethnic variability
・Develop Asian cohorts of inherited retinal disease
・Develop deep-phenotyping assessments of inherited retinal disease
・Develop novel therapeutic approaches for inherited retinal disease

Position: Honorary Research Associate (supervised by Prof Michel Michaelides)              2017-present      ・Develop novel therapeutic approaches for inherited retinal disease
・Clarify genotype-phenotype correlations for inherited retinal disease
・Establish ABCA4 world-wide cohort to investigate the ethnic variability

Position: Research Associate (supervised by Prof Michel Michaelides)                  2016-2017                       ・Establish ABCA4 world-wide cohort in collaboration with ProgStar studies
・Develop data-sharing system under UK-Japan collaboration
・Clarify genotype-phenotype correlations for inherited retinal disease

Position: Research Assistance (supervised by Prof Michel Michaelides, Prof Andrew Webster)      2009-2013
・Phenotype and genotype a cohort with Stargardt disease
・Identify genotype-phenotype association in ABCA4-assocaited retinal disorder
・Investigate longitudinal natural history of ABCA4-assocaited retinal disorder
・Promote therapeutic trials for ABCA4-assocaited retinal disorder
・Validate electrophysiological assessment for the diagnosis/prognosis of Stargardt disease


Moorfields Eye Hospital, London, UK                                        

Inherited Retinal Diseases
Position: Honorary Consultant                                      2018-present
・Development of novel therapies for inherited retinal disease
・Phenotype patients with inherited retinal disease

Inherited Retinal Diseases
Position: Honorary Practice Manager (supervised by Prof Michel Michaelides)                 2017-present
・Phenotype patients with inherited retinal disease

Position: Clinical Research Fellow (supervised by Prof Michel Michaelides, Prof Graham Holder, Prof Andrew Webster, Prof Anthony Moore, and Dr Anthony Robson)                         2009-2013                         ・Phenotype patients with inherited retinal disease


Nairobi University, Kenya                                        
Ophthalmology
Position: Honorary Professor                                      2022-present
・Development of genotype-phenotype correlations for inherited retinal disease
・Phenotype patients with inherited retinal disease

Tokyo University, Tokyo, Japan
Biological Sciences, Graduate School of Science
Position: Visiting Researcher
・Elucidate ancestor of inherited retinal disease
・Develop genome mathematical evolutionary analysis based on human genome diversity to understand inherited retinal disease

National Hospital Organization Tokyo Medical Center, Tokyo, Japan               
Ophthalmology/Medical Genetics

Position: Honorary Consultant Clinical Medical Geneticist                                   2020-
・Division head, division of inherited eye disease

Position: Honorary Consultant Ophthalmic Surgeon                                        2017-
・Division head, division of ophthalmic genetics

Position: Consultant Ophthalmologist                                                   2013-2016
・Faculty, division of vitreoretinal surgery
・Faculty, division of electrophysiology
・Faculty, division of ophthalmic genetics

Position: Resident (supervised by Prof Yozo Miyake and Prof Toru Noda)                  2006-2009                  ・General ophthalmology training
・General training for electrophysiology

Nagoya First Red Cross Hospital, Aichi, Japan                                      
・General Medicine
Position: Resident                                                                  2004-2006
・General medical training

 

PERSONAL DETAILS
44 years old
Place of Birth: Michigan, USA
Nationality: Japan


MARITAL STATUS
Married

LICENSE AND CERTIFICATION

2019         Specialist Certificate of Clinical Genetics issued by Japan Society of Human Genetics

(registry number; 1715)

2016         Doctor of Philosophy, issued by Keio University School of Medicine

2014        Diploma of Ophthalmology issued by Japanese Ophthalmological Society

                 (reference number; 017133)

2011     General Medical Certification, UK (temporal reference number; 7212651)

2004     Japanese Medical License Registration (registry number; 444194)

 

 

MEMBERSHIPS/BOARD

2021-         President, East Asia Inherited Retinal Disease Society

2020-         Board, ISCEV (International Society for Clinical Electrophysiology of Vision)

2019-         ClinGen (Clinical Genome Resource) Retina Gene Curation Expert Panel

2018          Chair, East Asia Inherited Retinal Disease Society

2018          Board, Japan Society for Clinical Electrophysiology and Vision

2016-         Member, ISER (International Society for Eye Research)

2016-         Co-principle Investigator, ProgStar: The International Study of Stargardt Disease

2016-         Chair, East Asia Inherited Retinal Disease Consortium

2015-         Member, The American Society of Human Genetics (ASHG)

2014-         Member, Japanese Society of Human Genetics

2014-         Board, Japan Eye Genetics Consortium

2014-         Board, Asian/Global Eye Genetics Consortium

2009-        Member, ISCEV (International Society for Clinical Electrophysiology of Vision)

2009-         Member, JSCEV (Japanese Society for Clinical Electrophysiology of Vision)

2006-        Member, ARVO (The Association for Research in Vision and Ophthalmology)

2005-         Member, Japanese Ophthalmological Society

 

 

JOURNAL BOARD

2021-       GENES guest editor of a special issue, titled ‘Ophthalmic Genetics’

2021-       DOCUMENTA OPHTHALMOLOGICA (Editorial board)

2020-       EYE GENETICS (Chief editor)

2018-      OPHTHALMIC RESEARCH (Editorial board)

2018-      Open Access Journal of Ophthalmology (Editorial board)

 

 

AWARDS

2021          SANTEN Trust Fund for Ophthalmic Research

2020          Tokyo Retina League, Young Investigator Award

2018          ASHG 2017 reviewer’s choice

2017          Japanese Retina and Vitreous Society (JRVS), Best Presentation Award

2016          FOUNDATION FIGHTING BLINDNESS Carrier Development Award

2015          Keio University Ushioda Memorial Award.

2014          Keio University Otsuka Fumon/Fusako Fellowship Award.

2013         National Institute for Health Research, Moorfields Biomedical Research Centre Travel Grant

                 (ARVO annual meeting 2013)

2012          Eberhart Dodt Memorial Award Best Presentation (ISCEV symposium 2012)

2010          ISCEV symposium travel grant 2010

2007         Eberhart Dodt Memorial Award Excellent Presentation (ISCEV symposium 2007)

TM20-048A_7349_4data.jpg

LICENSE AND CERTIFICATION

2019         Specialist Certificate of Clinical Genetics issued by Japan Society of Human Genetics

(registry number; 1715)

2016         Doctor of Philosophy, issued by Keio University School of Medicine

2014        Diploma of Ophthalmology issued by Japanese Ophthalmological Society

                 (reference number; 017133)

2011     General Medical Certification, UK (temporal reference number; 7212651)

2004     Japanese Medical License Registration (registry number; 444194)

 

 

MEMBERSHIPS/BOARD

2021-         President, East Asia Inherited Retinal Disease Society

2020-         Board, ISCEV (International Society for Clinical Electrophysiology of Vision)

2019-         ClinGen (Clinical Genome Resource) Retina Gene Curation Expert Panel

2018          Chair, East Asia Inherited Retinal Disease Society

2018          Board, Japan Society for Clinical Electrophysiology and Vision

2016-         Member, ISER (International Society for Eye Research)

2016-         Co-principle Investigator, ProgStar: The International Study of Stargardt Disease

2016-         Chair, East Asia Inherited Retinal Disease Consortium

2015-         Member, The American Society of Human Genetics (ASHG)

2014-         Member, Japanese Society of Human Genetics

2014-         Board, Japan Eye Genetics Consortium

2014-         Board, Asian/Global Eye Genetics Consortium

2009-        Member, ISCEV (International Society for Clinical Electrophysiology of Vision)

2009-         Member, JSCEV (Japanese Society for Clinical Electrophysiology of Vision)

2006-        Member, ARVO (The Association for Research in Vision and Ophthalmology)

2005-         Member, Japanese Ophthalmological Society

 

 

JOURNAL BOARD

2021-       GENES guest editor of a special issue, titled ‘Ophthalmic Genetics’

2021-       DOCUMENTA OPHTHALMOLOGICA (Editorial board)

2020-       EYE GENETICS (Chief editor)

2018-      OPHTHALMIC RESEARCH (Editorial board)

2018-      Open Access Journal of Ophthalmology (Editorial board)

 

 

AWARDS

2021          SANTEN Trust Fund for Ophthalmic Research

2020          Tokyo Retina League, Young Investigator Award

2018          ASHG 2017 reviewer’s choice

2017          Japanese Retina and Vitreous Society (JRVS), Best Presentation Award

2016          FOUNDATION FIGHTING BLINDNESS Carrier Development Award

2015          Keio University Ushioda Memorial Award.

2014          Keio University Otsuka Fumon/Fusako Fellowship Award.

2013         National Institute for Health Research, Moorfields Biomedical Research Centre Travel Grant

                 (ARVO annual meeting 2013)

2012          Eberhart Dodt Memorial Award Best Presentation (ISCEV symposium 2012)

2010          ISCEV symposium travel grant 2010

2007         Eberhart Dodt Memorial Award Excellent Presentation (ISCEV symposium 2007)

FUNDS/GRANTS

<Project leader>
(20 research projects; Total JPY 367,554,136 (=GBP 1,911,281.507; 1 JPY=0.0052GBP))

2024-    Contracted clinical trial
Title: A Phase 1b Open-label Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Tinlarebant in Japanese Subjects With Stargardt Disease and a Phase 2/3 Randomized, Double-masked, and Placebo-controlled Study to Evaluate the Safety, Tolerability, and Efficacy of Tinlarebant in Subjects With Stargardt Disease
ClinicalTrials.gov Identifier: NCT05244304
Responsible Party: Belite Bio, Inc


2023-    Contracted clinical trial
Title: A Post-Authorization, Multicenter, Multinational, Longitudinal, Observational Safety Registry
Study for Patients Treated with VoretigeneNeparvovec
Identifier: EUPAS31153
Responsible Party: Novartis Pharm Japan


2022-    Contracted clinical research
National Institute For Health and Care Research (NIHR) AI AWARD (UK): Eye2Gene: accelerating the diagnosis of inherited retinal diseases.
Identifier: Award AI_AWARD02488

 

2021-    Contracted clinical trial phase 0
Title: An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa
ClinicalTrials.gov Identifier: NCT04868916
Responsible Party: Janssen Pharmaceutical K.K. Adopted JPY 134,609,438 (=GBP 874,961)


2020-    Contribute Trust Fund for Ophthalmic Research in Commemoration of Santen Pharmaceutical’s Founder.
Title: Identification of ancestor of Miyake disease with utilizing genomic variation analysis.
JPY 2,000,000 (=GBP 15,098)


2019-    Contracted clinical trial phase 0
Title: Extended Calibration of Visual Function Evaluation Tests in Patients With Severe Vision Loss 2.
ClinicalTrials.gov Identifier: NCT03281005
Responsible Party: Astellas Pharma Inc. Adopted JPY 32,233,695 (=GBP 243,332)


2018-    National Hospital Organization Network Research Fund
Title: Development of a diagnosis support system in Ophthalmology, utilizing artificial intelligence. (Reference: H30-NHO (Sensory organs)-3 JPY 58,500,000 for application/3 years) (=GBP 441,616).


2018-    Contracted clinical trial phase 0
Title: Extended Calibration of Visual Function Evaluation Tests in Patients With Severe Vision Loss.
ClinicalTrials.gov Identifier: NCT03281005
Responsible Party: Astellas Pharma Inc. JPY 43,335,033 (=GBP 327,136)


2017-    Contracted clinical trial phase 0
Title: Calibration of Visual Function Evaluation Tests in Patients With Severe Vision Loss.
ClinicalTrials.gov Identifier: NCT03281005
Responsible Party: Astellas Pharma Inc. JPY 13,942,179 (= GBP 105,249)


2017-    Grant-in-Aid for Scientists to support international collaborative studies of the Ministry of Education, Culture, Sports, Science and Technology, Japan.
Title: Establishment of an intercontinental cohort database for ABCA4-associated retinal disorder in global eye genetic consortium, including 7 countries from Europe, America, and Asia (grant reference: 16KK01930002; JPY 12,480,000/ 2 years) (= GBP 94,211).


2016-    Grant-in-Aid for Young Scientists (A) of the Ministry of Education, Culture, Sports, Science and Technology, Japan.
Title: Establishment of an intercontinental cohort database for ABCA4-associated retinal disorder, aiming for clinical trial of treatment (grant reference: 16H06269; JPY 24,310,000/ 3 years) (=GBP 183,516).


2016    FOUNDATION FIGHTING BLINDNESS ALAN LATIES CAREER DEVELOPMENT PROGRAM, Clinical/Research Fellowship Award in Inherited Orphan Retinal Degenerations (USD 65,000) (=JPY 7,014,150; =GBP 52,961).


2015    Grants for International Activities in Life Sciences and Medicine, Keio University Medical Science     Fund.
   Title: A collaborative research of genotype-phenotype correlation in a large international cohort with inherited retinal disease: investigation of molecular modeling impact and clinical severity. (JPY 200,000) (=GBP 1,509)


2014    Grants for International Activities in Life Sciences and Medicine, Keio University Medical Science     Fund.
Title: Clinical and Genetic Characteristics of Childhood-onset Stargardt Disease. (JPY 200,000) (=GBP 1,509)


2013    Grant-in-Aid for Young Scientists (B) of the Ministry of Education, Culture, Sports, Science and     Technology, Japan (Ref: 25861662).
   Title: Clinical and molecular genetic investigation of inherited macular disease, aiming for clinical     trial of treatment. (JPY 4,300,000/ 2 years)(=GBP 32,460)


2011     Daiwa Anglo-Japanese Foundation, Daiwa foundation small grant (Ref: 8608/9273)
   Title: Support for three reciprocal UK-Japan visits by Ophthalmologists to carry out         collaborative research into the clarification of genotype-phenotype correlations of retinal     dystrophies leading to publications and conference papers. (GBP 3,000) (= JPY 397,151)


2010     Suzuken Memorial Investigative Research Fund
   Title: Clinical and molecular genetic investigation of inherited macular disease in preparation for     clinical trial (JPY 1, 000,000) (=GBP 7,549).


2010     Mitsukoshi International Research Award
   Title: Clinical and molecular genetic investigation of inherited macular disease in preparation for     clinical trial. (JPY 600,000) (=GBP 4,529).


2010    Fight for sight, DR HANS AND MRS GERTRUDE HIRSCH AWARDS (Ref: 1969U)
   Title: Investigation of the natural history of ABCA4-retinopathy in preparation for             treatment trials. (GBP 15,000) (=JPY 1,985,759)


2010    Special Trustees of Moorfield Eye Hospital (Reg: 228064)
   Title: Investigation of the natural history of ABCA4-retinopathy in preparation for             treatment trials. (GBP 7,500) (=JPY 992,879)

<Co-principal investigator>

(7 research projects; Total JPY1,597,551,273 (=GBP 9,904,817.8926))

2022-    National Institute For Health and Care Research (NIHR) AI AWARD 
Title: Eye2Gene: accelerating the diagnosis of inherited retinal diseases (JPY 207,719,040/ 3 years). (=GBP 1,290,501)

 

2020-    Japan Agency for Medical Research and Development
Title: Establishment of patients registry for juvenile patients with deaf/blindness. (Board, JPY 42,408,000/ 3 years). (=GBP 320,137)


2017-    Butterfield Awards for UK-Japan collaboration in medical research and public health practice
Title: UK-Japan Genomic Research of Inherited Eye Disease (Co-PI: GBP 11,000/ 3 years) (=JPY 1,456,223)


2017-     Health Labour Sciences Research Grant, The Ministry of Health Labour and Welfare.
Title: Establishment of comprehensive clinical management for juvenile patients with deaf/blindness. (Co-PI: JPY 18,000,000/ 3 years) (=GBP 135,882)


2016-    National Hospital Organization Network Research Fund
Title: Development of novel comprehensive gene screening methodology for the molecular diagnosis of retinitis pigmentosa. (Co-PI, JPY 60,000,000/ 3 years) (=GBP 452,940)


2016-   Foundation Fighting Blindness, multi central study
Title: THE PROGRESSION OF ATROPHY SECONDARY TO STARGARDT DISEASE (PROGSTAR) STUDIES (http://progstar.org/) (Co-PI, USD 4,800,000) (=JPY 517,968,000; GBP 3,911,025).


2015    Approved eyeGENE© Stage 2 Research Studies, National Eye Institute, National Institute of Health
   Title: Molecular Modeling of Pathogenic Mutations in Nucleotide-binding Domains of ABCA4 Transporter Protein.


2011-    Japan Agency for Medical Research and Development
   Title: Acquisition, administration, and provision of biological samples and elucidation of pathology in hereditary retinal and choroidal disorders. (Board, JPY 750,000,000/ 9 years)(=GBP 5,661,750)

CLINICAL TRIALS

1.    Clinical Trial of Gene Therapy for Japanese Patient with Inherited Retinal Dystrophy Caused by Biallelic RPE65 Mutations (Clinical trial. Gov: NCT04516369).
Phase 3 trial. Novartis Japan
Approved by Pharmaceuticals and Medical Devices Agency in December 2019. 
Approved by Institutional Review Board in January 2020.
Role: professional medical supervisor

2.    Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene (Clinical trial. Gov: NCT05926583).
Phase 3 trial. Janssen Pharma Japan
Approved by Pharmaceuticals and Medical Devices Agency in December 2023. 
Approved by Institutional Review Board in January 2023.
Role: advisory

 

CONFERENCE/COURSE CHAIR

2022    3rd Symposium of East Asia Inherited Retinal Disease Society
          Hosted by Kaoru Fujinami, Laboratory of Visual Physiology, Division of Vision Research, National      Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center.
     Virtual. Tokyo, Japan. 19th March 2022.

 

2020         2nd Symposium of East Asia Inherited Retinal Disease Society

                 Hosted by Kaoru Fujinami, Laboratory of Visual Physiology, Division of Vision Research,     

                National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center.

                 Virtual. Tokyo, Japan. 14th November 2020.

 

2019         1st Symposium of East Asia Inherited Retinal Disease Society

                 Hosted by Kaoru Fujinami, Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center and Se Joon Woo, Seoul national university bundang hospital, South Korea.

                 Seoul National University Bundang Hospital, Healthcare Innovation Park, Seoul, South Korea,11th October 2019

 

2018         1st East Asia Inherited Retinal Disease Society seminar and courses

                 Hosted by Kaoru Fujinami, Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center

                 National Institute of Sensory Organs, Tokyo, Japan, 5th-9th November 2018

 

2014         International Ophthalmic Genetics Meeting 2014 at Tokyo

Hosted by Kaoru Fujinami, Laboratory of Visual Physiology, Division of Vision Research, National Institute of Sensory Organs, National Hospital Organization, Tokyo Medical Center

JP tower, Tokyo, Japan, 1st April 2014

Invited lectures

(Total 99 lectures, including 52 international and 47 domestic lectures)

  1. The 64th Annual Meeting of the Ophthalmological Society of Taiwan

Title: Study of Efficacy and Safety of Voretigene Neparvovec in Japanese Patients With Biallelic RPE65 Mutation-associated Retinal Dystrophy

Taipei Nangang Exhibition Center, Taipei, Taiwan (WEB), 18th November 2023

 

  1. 16th APVRS 2023

Title: ABCA4 Related Diseases

Hongkong convention and exhibition centre, Hong Kong, China,

10th, December 2023

 

  1. The 3rd Asia Retina Congress

Title: Occult Macular Dysfunction Syndrome: Identification of multiple causative genes of macular dysfunction with normal fundus

PACIFICO Yokohama, Kanagawa, 13th November 2023

 

  1. 60th Symposium of the International Society for Clinical Electrophysiology of Vision (ISCEV)

Title: Electrical evoked potentials

ISCEV 2023, KYOTO, 2023, 18th March, 2023.

 

  1. 60th Symposium of the International Society for Clinical Electrophysiology of Vision (ISCEV)

Title: Application of visual electrodiagnosis for retinal gene therapy

ISCEV Course 2023, KYOTO, 14th March, 2023.

 

  1. The 15th Asia-Pacific Vitreo-retina Society Congress

Inherited Retinal Disease: An Approach from Diagnosis to Gene Therapy

Inherited retinal diseases

Taipen Nangang Exhibision Center Hall, 19th November 2022.

 

  1. The 22nd Suidobashi Ophthalmology Forum

Title: Inherited retinal diseases: Topics of gene therapy.

Grand Hyatt Tokyo, Tokyo, Japan, 10th November, 2022.

 

  1. The 23th European Association for Vision and Eye Research Congress

Title: Japan Eye Genetics Consortium; a platform of genes, phenotypes, and application of AI

Genes phenotypes and Artificial Intelligence

Valencia Conference Center, Valencia, Spain, 13th October, 2022

 

  1. The 76th Annual Congress of Japan Clinical Ophthalmology

Title: Approaches for inherited retinal dystrophy

New Approaches and Medical Technologies for Intractable Ophthalmic Diseases

Tokyo International Forum, Tokyo, Japan, 15th October, 2022.

 

  1. 59th International Society of Clinical Electrophysiology and Vision (ISCEV) Symposium and Courses

Title: Application of visual electrodiagnosis for retinal gene therapy

ISCEV Course Human Day 2

Central Teaching Hub, University of Liverpool, 2nd August, 2022.

 

  1. The 126th Annual Meeting of Japanese Ophthalmological Society

Title: Gene therapy for inherited retinal diseases: from diagnosis to treatment

New Approaches to Hereditary Retinal Diseases

Title: Retinal dystrophy

Update in chorioretinal imaging

Osaka International Convention Center, RIHGA Royal Hotel Osaka, Japan, 15th April, 2022.

 

  1. The 16th Japan Retinitis Pigmentosa Society Forum, Tokyo, Japan

Title: Clinical applications of gene therapy.

Japan. WEB, 27th, March 2022.

 

  1. The 43th Comparative Ophthalmology Society Foundation Research Society

Title: Inherited retinal disease: current and future perspectives on treatment introduction.

Japan. WEB, 12th, March 2022.

 

  1. NUH/NUS 36TH Anniversary International Eye Conference.

Title: Macular Dystrophy and Updates on ABCA4-Retinopathy

National University of Singapore, Singapore WEB, 21st, January 2022.

 

  1. The 10th Teikyo Kawasaki Ophthalmology Conference

Title: Inherited Retinal Disease: understanding of pathophysiology

Kanagawa, Japan. WEB, 20th, November 2021.

 

  1. The 4th International Conference of Genomics on EYE

Title: Nationwide and international cohort studies of inherited retinal disease: Japan Eye Genetics Consortium and East Asia Inherited Retinal Disease Society

China, WEB, 16th, November 2021.

 

  1. 20th Kitakanto Ophthalmology Conference

Title: Treatment of inherited retinal disease

Tochigi, Japan. WEB, 10th, November 2021.

 

  1. 17th KSCEV Annual Symposium

Title: Inherited retinal disease: an approach from diagnosis to gene therapy

Korea, WEB, 16th, October, 2021.

 

  1. The 66th Annual Meeting of the Japanese Society of Human Genetics

Title: Visual Impairment

Pacifico Yokohama, Kanagawa, Japan, 14th, October, 2021.

 

  1. Kyorin University, Ophthalmology Open Conference 2021, Tokyo, Japan

Title: Structure and Function of Inherited Retinal Disease: pathophysiology to treatment.

Kyorin Eye Center Conference Hall, Kyorin Eye Center, Kyorin University, 29th, September, 2021.

 

  1. Japan Retinitis Pigmentosa Society Niigata Symposium 2021, Niigata, Japan

Title: Inherited Retinal Disease: an approach from diagnosis to treatment.

Niigata City General welfare hall, Virtual, Niigata, Japan, 30th May, 2021.

 

  1. The 10th annual meeting of Japan Perimetric Society, Tokyo, 2021

Title: Structure and function of inherited retinal disease -pathophysiology to treatment-

Web, 25th April, Tokyo, Japan, 2021

 

  1. The 124th Annual Meeting of the Japanese Ophthalmological Society, Tokyo, Japan

Title: Gene therapy -current picture-

Osaka International Congress Center, Web, 8th April – 11th April, Osaka, Japan, 2021

 

  1. 37th World Ophthalmology Congress 2020

Electrophysiologic and Other Diagnostic Testing in Neuro-ophthalmology

Title: Basics and clinical applications of electrophysiologic testing in neuro-ophthalmology

WOC2020 Virtual®, 26–29 June, Cape town, South Africa, 2020

 

  1. The 123rd Annual Meeting of the Japanese Ophthalmological Society, Tokyo, Japan

Title: Diseases with night blindness and their managements.

Education seminar 2. Retinal diseases and electrophysiology

Title: Diseases with night blindness and their managements.

Subspecialty Sunday. Recent advancement of Medical Retina

Tokyo International Forum, Web, 27th April – 18th May, Tokyo, Japan, 2020

 

  1. Lion Eye Institute Seminar series 2020

Title: Clinical and Genetic Characteristics of East Asian Patients with Inherited Retinal Disorders

Harry Perkins Institute, ground floor Seminar room G24, Perth, Australia, 5th February 2020

 

  1. 1st Symposium of East Asia Inherited Retinal Disease Society.

Title: Overview of EAIRDs.

Title: East Asia inherited retinal disease studies: clinical and genetic characteristics of inherited retinal disease in Japanese population.

Seoul National University Bundang Hospital, Healthcare Innovation Park, Seoul, South Korea,11th October 2019.

 

  1. Seoul National University Bundang Hospital Ophthalmology Conference

Title: Nationwide and international collaborative studies of inherited retinal diseases: East Asia Inherited Retinal Disease Society

Seoul National University Bundang Hospital Lecture theatre, Seoul, South Korea,10th October 2019.

 

  1. 57th Annual Symposium of the International Society for Clinical Electrophysiology of Vision (ISCEV)

Title: East Asia Inherited Retinal Disease Studies; Clinical and Genetic Characteristics of Inherited Retinal Disease in Japanese Population.

Session-6 East Asia Inherited Retinal Disease Studies (EAIRDs)

Grand Ambassador Seoul Associated Pullman. 9th October 2019. Seoul, Korea.

 

  1. Japan Retinitis Pigmentosa Society Yamagata Symposium 2019, Yamagata, Japan

Title: Inherited Retinal Disease: an approach from diagnosis to treatment.

Terusa Yamagata Aplause, Yamagata, Japan, 22th September, 2019.

 

  1. International Society for Genetic Eye Diseases and Retinoblastoma (ISGEDR) 2019

Title: Clinical and Genetic Characteristics of East Asian Patients with Inherited Retinal Disorders.

Justus-Liebig University, Giessen, Germany, 31st August, 2019

 

  1. 80th Saitama Ophthalmology Congress

Title: Inherited retinal disorder: a comprehensive approach from diagnosis to treatment.

Prince Hotel Kawagoe, Saitama, Japan, 2nd August, 2019

 

  1. 1st Retinal Hemodynamics Seminar

Title: Nationwide and international collaborative studies; retinal genomics research in Japan and East Asian countries.

HOTEL GRANVIA, Kyoto, Japan, 6th July, 2019.

 

  1. 1st UK-Japan retinal hemodynamics symposium,

Title: Nationwide and international collaborative studies; retinal genetics and vascular disorders.

Imperial Hotel/National Institute of Sensory Organs, Tokyo Japan, 1st July, 2019.

 

  1. 14th Japan Retinitis Pigmentosa Society Forum, Tokyo, Japan

Title: Update of treatment for retinitis pigmentosa in the world -a comprehensive approach from diagnosis to treatment-

KFC Hall, Tokyo, Japan, 30th June 2019

 

  1. JSCEV 67th symposium

Title: Total cohort survey of JEGC studies

Title: Miyake’s disease and allied disorders

Title: Treatment for inherited retinal disorders: emerging therapeutic options

KFC Hall, Tokyo, Japan, 28th -29th June 2019

 

  1. The 123rd Annual Meeting of the Japanese Ophthalmological Society, Tokyo, Japan

Title: Genetic diagnosis aiming for therapy.

Tokyo International Forum, 18th April, Tokyo, Japan, 2019

 

  1. Keio University, Department of Ophthalmology, PhD course Spring Seminar 2019

Title: Nationwide and international network survey of inherited retinal disease: diagnosis, origin identification, and treatment

Keio University School of Medicine, Tokyo, Japan, 30th March 2019.

 

  1. Genomics Research Conference 2019

Title: Nationwide Ophthalmic Genetics Researches in Japan

Moorfields Eye Hospital, London, UK, 28th February 2019.

 

  1. Japanese Society of Hemorheology and Eas Asia Inherited Retinal Disease Society Joint meeting 2019

Title: Basics and advancement of retinal imaging; molecular and electrophysiological mechanisms of the retina.

Yokokawa Clinic Lecture Theatre, Osaka, Japan, 28th January 2019.

 

  1. 1st East Asia Inherited Retinal Disease Society Seminar and Courses, Tokyo, Japan

Title: Laboratory of Visual Physiology, National Institute of Sensory Organs: history and science

Title: Paediatric Stargardt Disease

National Institute of Sensory Organs, Tokyo Japan, 5th-9th November, 2018.

 

  1. The 120th Annual Meeting of the Korean Ophthalmology Society, Seoul, Korea.

Clinical electrophysiology symposium

Title: Nationwide and International studies of Inherited Retinal Disorders: Japan Eye Genetics Consortium and East Asia Inherited Retinal Disease

COEX, 2nd, November 2018.

 

  1. The 72nd Annual Congress of Japan Clinical Ophthalmology, Tokyo, Japan

Mechanism and Diagnosis in Paediatric Hereditary Retinal Disorders

Title: ABCA4-associated retinal disorder

Tokyo International Forum, Tokyo Japan, 11th October 2018.

 

  1. Germany-Japan Collaborative Research Congress 2018, Tubingen, Germany

Title: Autosomal Dominant Occult Macular Dystrophy (Miyake's disease):

nationwide and international collaborative studies.

Title: Genetic variability of ABCA4 associated with ethnicity in an international cohort with Stargardt disease: ProgStar and EAStar studies

Institute of Ophthalmic Research, Tubingen University, Tubingen, Germany, 11th September 2018.

 

  1. France-Japan Collaborative Genomic Research Meeting 2018, Paris, France

Title: Nationwide and international collaborative studies in Inherited retinal disorder

Institute de LA VISION, Paris, France, 25th June 2018.

 

  1. Japan Retinitis Pigmentosa Society Tokyo Symposium 2018, Tokyo, Japan

Title: Inherited Retinal Disease: a general concept from diagnosis to treatment,

Poppo Machida, 9th June, 2018.

 

  1. 15th Japan Retinitis Pigmentosa Society Osaka Symposium, Osaka, Japan

Title: Inherited Retinal Disease: an approach from diagnosis to treatment,

Osaka Citizen Center, 20th May, 2018.

 

  1. 36th World Ophthalmology Congress 2018

Latest Therapies for Genetic Disorders: Symposia (Retinal Dystrophies, Corneal Dystrophies, Optic Nerve Conditions

Title: Stargardt disease

Fira Gran Via conference center, Barcelona, Spain, 18th June 2018.

 

  1. Research Organization of Information and Systems, National Institute of Genetics forum 2017, Shizuoka, Japan

Front edge and fusion of genomic medicine and bioinformatics

Title: Nationwide and international collaborative studies of inherited retinal disease: an approach from diagnosis to treatment,

Research Organization of Information and Systems, National Institute of Genetics, Shizuoka, Japan, 28th March, 2018.

 

  1. National teaching course 2018, Chongqing, China

Hereditary retinal disease and infectious retinal disease

Title: Nationwide and international collaborative studies of inherited retinal disease: an approach from diagnosis to treatment,

Chongqing library, Chongqing, China, 24th March 2018.

 

  1. Ophthalmic genetics seminar 2018, Henan, China, 6th February 2018.

Title: East Asia Inherited Retinal Disease Consortium

Henan Eye Institute, Henan Provincial People's Hospital, Henan, China, 6th February 2018.

 

  1. The 56th Annual Meeting of Japanese Retina and Vitreous Society (JRVS)

Title: Genetic Characteristics of Occult Macular Dystrophy in East Asia

Tokyo International Forum, Tokyo, Japan, 1st December 2017

 

  1. 12th Japan Retinitis Pigmentosa Society Forum, Osaka, Japan

Title: Inherited Retinal Disease -an approach from diagnosis to treatment-

Senri Life Science Center, Osaka, Japan, 19th November 2017.

 

  1. 6th Japan-Korea Joint Symposium of Clinical Electrophysiology of Vision, Osaka, Japan

Recent Research on Clinical Electrophysiology of Vision in Our Countries.

Title: Nationwide and International Collaborative Studies of Inherited Retinal Disease; East Asia Inherited Retinal Disease Consortium.

Senri Life Science Center, Osaka, Japan, 18th November 2017.

 

  1. The 71st Annual Congress of Japanese Clinical Ophthalmology, Tokyo, Japan

Clinical Science of Macula

Title: Macular function -Electrophysiology in Macular Dystrophy-

Tokyo International Forum, Tokyo, Japan, 13th October 2017

 

  1. The 121st Annual Meeting of the Japanese Ophthalmological Society, Tokyo, Japan

65th Lectures for Ophthalmology Specialist

Title: The importance of nationwide and international collaboration in hereditary orphan diseases.

Tokyo International Forum, Tokyo, Japan, 8th April 2017

 

  1. 32nd APAO Congress, Singapore

ISCEV Symposium: Clinical Electrophysiology of Vision

Title: Electrophysiology in Macular Dystrophy.

Suntec Singapore Convention and Exhibition Centre, Singapore, 3rd March 2017.

 

  1. The 1st University of Manchester-National Institute of Sensory Organs Collaborative Meeting on Ophthalmic Genetics, Manchester, UK

Title: Data sharing of Global Eye Genetics Consortium in inherited retinal disease

Manchester Royal Eye Hospital, Manchester, UK, 30th January 2017.

 

  1. The 1st Chili-Japan Collaborative Conference of Ophthalmic Genetics, Santiago, Chile

Title: Data sharing of Japan/Asia Eye Genetics Consortium in inherited retinal disease

Hospital del Salvador, Universidad de Chile, Santiago, Chile, 24th January 2017.

 

  1. XXII Biennial Meeting of the ISER, the Lunch symposium, Tokyo, Japan

Title: Occult Macular Dystrophy (Miyake's disease); nationwide and international collaborative studies

The Keio Plaza Hotel, Tokyo, Japan, 26th September 2016.

 

  1. The 5th Global Chinese Ophthalmic Conference, Suzhou, China

Title: MIYAKE’S DISEASE: GENTYPE AND PHOTORECEPTOR MICROSTRUCTURAL PHENOTYPE ASSOCIATIONS IN OCCULT MACULAR DYSTROPHY

Suzhou International Expo Center, Suzhou, China, 9th September 2016.

 

  1. The 1st China-Japan Collaborative Conference in Ophthalmic Genetics, Beijing, China

Title: Hereditary Macular Dystrophy: a nationwide/international collaborative study

Peking Union Medical College Hospital, Beijing, China, 7th September 2016.

 

  1. Ophthalmic Genetics Seminar 2016, London, UK

Title: Inherited retinal disease in Japanese population

UCL Institute of Ophthalmology, London, UK, 17th February 2016.

 

  1. 4th Japan-Korea Joint Symposium of Clinical Electrophysiology of Vision, Seoul, South Korea

Title: Japan whole exome project for inherited retinal diseases 2014.

Gangdong Sacred Heart Hospital, Seoul, South Korea, 31st October 2015.

 

  1. Seminar of the Ophthalmic Genetics and Visual Function Branch, National Eye Institute, National Institute of Health, Bethesda, MA, USA.

Title: ABCA4-associated retinal disorder -Translational approach aiming for treatment-.

National Eye Institute, National Institute of Health, Bethesda, MA, USA, 7th October 2015

 

  1. The 9th APVRS Congress (Asia Pacific Vitreo-retina Socoity), Sydney, Australia, 2015

Title: Comprehensive clinical and electrophysiological assessment crucial for targeted genetic screening and molecular genetic diagnosis.

Hilton Sydney, Australia, 1st August 2015

 

  1. Asia-Pacific Academy of Ophthalmology (APAO) congress 2015

ISCEV Symposium: Progress in Electrophysiology of Vision

Title: Stargardt disease with foveal sparing phenotype.

Guangzhou Baiyu International Convention Center, Guangzhou, China, 1st April 2015

 

  1. Asia-ARVO 2015, Tokyo, Japan, 2015

Mechanism of Retinal Degeneration

Title: Stargardt disease with foveal sparing phenotype.

Pacifico Yokohama, Kanagawa, Japan, 18th February 2015

 

  1. Genetics Conference, New York, NY 2014

Title: ABCA4-related retinal disorder -up to date-

Edward Howkins Institute, Columbia University, New York, NY, USA, 29th July 2014

 

  1. The 3rd annual meeting of Japan Perimetric Society, Tokyo, 2014

Title: Macular dystrophy ~Function, Morphology and Pathophysiology~

The Shinagawa grand hall, Tokyo, Japan, 29th June 2014

 

  1. Medical Retina Meeting at Monza, Italy 2013

Title: Genotype-Phenotype Correlation in Inherited Retinal Disease

San Gerardo Hospital, Monza, Italy, 29th October 2013

 

  1. Electrophysiology Course at Pavia, Italy 2013

Title: Genotype-Phenotype Correlation in Macular Dystrophy

San Matteo Hospital, Pavia, Italy, 28th October 2013

 

  1. Ophthalmic Genetics Conference at Ljubljana Slovenia 2013

Title: Phenotype and Genotype of Stargardt Disease -updated-

Ljubljana University Medical Centre, Ljubljana, Slovenia, 25th October 2013

 

  1. Retina updated meeting at Chongqing China 2013

Title: Genotype-phenotype correlations in Inherited Retinal Disease

Southwest Eye Hospital, Third Military Medical University, Chongqing, China, 10th October 2013

 

  1. Japanese Society of Clinical Electrophysiology and Vision (JSCEV) 60th symposium

Title: Inherited Retinal Disease and Molecular Genetics Genotype-Phenotype Correlation

Midland Hall, Nagoya, Japan, 6th October 2012

 

  1. ISCEV symposium at European Association for Vision and Eye Research annual meeting 2011

Title: Progression of Electroretinogram Responses in Stargardt-Fundus Flavimaculatus: A longitudinal study

Creta Maris Convention Center, Hersonissos, Crete, Greece, 8th October 2011

 

  1. Medical Retina Meeting in Collaboration with the Quinze-Vingts Hospital, Paris, France

Title: A Longitudinal Study of the Electroretinogram Responses in Stargardt-Fundus Flavimaculatus

Quinze-Vingts Hospital, Paris, France, 12th May 2010

TEACHING, TRAINING, AND MENTORING

1. Ophthalmology trainee (2009-2014); academic supervisor

2. Ophthalmology trainee (2010-2015); academic supervisor

3. Ophthalmology trainee (2011-2014); academic supervisor

4. Ophthalmology trainee (2011-2013); academic supervisor

5. Ophthalmology trainee (2012-2015); academic supervisor

6. Ophthalmology trainee (2013-2016); academic supervisor

7. PhD student (2017-2021); primary supervisor

8. PhD student (2018-); primary supervisor

9. PhD student (2018-); co-supervisor

10. MD student (2018-2020); primary supervisor

11. PhD student (2020-); primary supervisor

12. PhD student (2021-); primary supervisor

13. PhD student (2022-); primary supervisor

PEER-REVIEWED PUBLICATIONS 
 

132 publications on PubMed; 33 as first author, 20 as corresponding author

Total impact factor (IF): 584.926 (Journal of Citation Reports).

Google Scholar Citations: 3871 (3183 since 2019), h index 32, i10 index 78 (69 since 2019)

  1. Fujinami K, Nishiguchi KM, Oishi A, Akiyama M, Ikeda Y; Research Group on

Rare, Intractable Diseases (Ministry of Health, Labour, Welfare of Japan).

Specification of variant interpretation guidelines for inherited retinal

dystrophy in Japan. Jpn J Ophthalmol. 2024 Jul 30. doi:

10.1007/s10384-024-01063-5. Epub ahead of print. PMID: 39078460.

 

  1. Jolly JK, Grigg JR, McKendrick AM, Fujinami K, Cideciyan AV, Thompson DA,

Matsumoto C, Asaoka R, Johnson C, Dul MW, Artes PH, Robson AG. ISCEV and IPS

guideline for the full-field stimulus test (FST). Doc Ophthalmol. 2024

Feb;148(1):3-14. doi: 10.1007/s10633-023-09962-7. Epub 2024 Jan 18. PMID:

38238632; PMCID: PMC10879267.

 

  1. Woof W, de Guimarães TAC, Al-Khuzaei S, Varela MD, Sen S, Bagga P, Mendes B,

Shah M, Burke P, Parry D, Lin S, Naik G, Ghoshal B, Liefers B, Fu DJ, Georgiou

M, Nguyen Q, da Silva AS, Liu Y, Fujinami-Yokokawa Y, Kabiri N, Sumodhee D,

Patel P, Furman J, Moghul I, Sallum J, De Silva SR, Lorenz B, Holz F, Fujinami

K, Webster AR, Mahroo O, Downes SM, Madhusuhan S, Balaskas K, Michaelides M,

Pontikos N. Quantification of Fundus Autofluorescence Features in a Molecularly

Characterized Cohort of More Than 3000 Inherited Retinal Disease Patients from

the United Kingdom. medRxiv [Preprint]. 2024 Mar 28:2024.03.24.24304809. doi:

10.1101/2024.03.24.24304809. PMID: 38585957; PMCID: PMC10996753.

 

  1. Hitti-Malin RJ, Panneman DM, Corradi Z, Boonen EGM, Astuti G, Dhaenens CM,

Stöhr H, Weber BHF, Sharon D, Banin E, Karali M, Banfi S, Ben-Yosef T, Glavač D,

Farrar GJ, Ayuso C, Liskova P, Dudakova L, Vajter M, Ołdak M, Szaflik JP,

Matynia A, Gorin MB, Kämpjärvi K, Bauwens M, De Baere E, Hoyng CB, Li CHZ,

Klaver CCW, Inglehearn CF, Fujinami K, Rivolta C, Allikmets R, Zernant J, Lee W,

Podhajcer OL, Fakin A, Sajovic J, AlTalbishi A, Valeina S, Taurina G, Vincent

AL, Roberts L, Ramesar R, Sartor G, Luppi E, Downes SM, van den Born LI, McLaren

TL, De Roach JN, Lamey TM, Thompson JA, Chen FK, Tracewska AM, Kamakari S,

Sallum JMF, Bolz HJ, Kayserili H, Roosing S, Cremers FPM. Towards Uncovering the

Role of Incomplete Penetrance in Maculopathies through Sequencing of 105

Disease-Associated Genes. Biomolecules. 2024 Mar 19;14(3):367. doi:

10.3390/biom14030367. PMID: 38540785; PMCID: PMC10967834.

 

  1. Sen S, Fabozzi L, Fujinami K, Fujinami-Yokokawa YU, Wright GA, Webster A,

Mahroo O, Robson AG, Georgiou M, Michaelides M. IQCB1 (NPHP5)-Retinopathy:

Clinical and Genetic Characterization and Natural History. Am J Ophthalmol. 2024

Aug;264:205-215. doi: 10.1016/j.ajo.2024.03.009. Epub 2024 Mar 23. PMID:

38522724.

 

  1. Katta M, de Guimaraes TAC, Fujinami-Yokokawa Y, Fujinami K, Georgiou M,

Mahroo OA, Webster AR, Michaelides M. Congenital Stationary Night Blindness

Structure, Function and Genotype-Phenotype Correlations in a Cohort of 122

Patients. Ophthalmol Retina. 2024 Mar 24:S2468-6530(24)00121-0. doi:

10.1016/j.oret.2024.03.017. Epub ahead of print. PMID: 38522615.

 

  1. Hashem SA, Georgiou M, Fujinami-Yokokawa Y, Laich Y, Daich Varela M, de

Guimaraes TAC, Ali N, Mahroo OA, Webster AR, Fujinami K, Michaelides M.

Genetics, Clinical Characteristics, and Natural History of PDE6B-Associated

Retinal Dystrophy. Am J Ophthalmol. 2024 Jul;263:1-10. doi:

10.1016/j.ajo.2024.02.005. Epub 2024 Feb 15. PMID: 38364953.

 

  1. Laich Y, Georgiou M, Fujinami K, Daich Varela M, Fujinami-Yokokawa Y, Hashem

SA, Cabral de Guimaraes TA, Mahroo OA, Webster AR, Michaelides M. Best

Vitelliform Macular Dystrophy Natural History Study Report 1: Clinical Features

and Genetic Findings. Ophthalmology. 2024 Jul;131(7):845-854. doi:

10.1016/j.ophtha.2024.01.027. Epub 2024 Jan 24. PMID: 38278445.

 

  1. Georgiou M, Robson AG, Fujinami K, de Guimarães TAC, Fujinami-Yokokawa Y,

Daich Varela M, Pontikos N, Kalitzeos A, Mahroo OA, Webster AR, Michaelides M.

Phenotyping and genotyping inherited retinal diseases: Molecular genetics,

clinical and imaging features, and therapeutics of macular dystrophies, cone and

cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone

dysfunction syndromes. Prog Retin Eye Res. 2024 May;100:101244. doi:

10.1016/j.preteyeres.2024.101244. Epub 2024 Jan 24. PMID: 38278208.

 

  1. Fujinami-Yokokawa Y, Joo K, Liu X, Tsunoda K, Kondo M, Ahn SJ, Robson AG,

Naka I, Ohashi J, Li H, Yang L, Arno G, Pontikos N, Park KH, Michaelides M,

Tachimori H, Miyata H, Sui R, Woo SJ, Fujinami K§; East Asia Inherited Retinal

Disease Society Study Group*. Distinct Clinical Effects of Two RP1L1 Hotspots in

East Asian Patients With Occult Macular Dystrophy (Miyake Disease): EAOMD Report

4. Invest Ophthalmol Vis Sci. 2024 Jan 2;65(1):41. doi: 10.1167/iovs.65.1.41.

PMID: 38265784; PMCID: PMC10810149.

 

  1. Wong WM, Tham YC, Simunovic MP, Chen FK, Luu CD, Chen H, Jin ZB, Shen RJ, Li

S, Sui R, Zhao C, Yang L, Bhende M, Raman R, Sen P, Ghosh A, Poornachandra B,

Sasongko MB, Arianti A, Chia V, Mangunsong CO, Manurung F, Fujinami K, Ikeda H,

Woo SJ, Kim SJ, Mohd Khialdin S, Othman O, Bastion MC, Kamalden AT, Lott PWP,

Fong K, Shunmugam M, Lim A, Thapa R, Pradhan E, Rajkarnikar SP, Adhikari S,

Ibañez BMBI, Koh A, Chan CMM, Fenner BJ, Tan TE, Laude A, Ngo WK, Holder GE, Su

X, Chen TC, Wang NK, Kang EY, Huang CH, Surawatsatien N, Pisuchpen P, Sujirakul

T, Kumaramanickavel G, Singh M, Leroy B, Michaelides M, Cheng CY, Chen LJ, Chan

HW. Rationale and protocol paper for the Asia Pacific Network for inherited eye

diseases. Asia Pac J Ophthalmol (Phila). 2024 Jan-Feb;13(1):100030. doi:

10.1016/j.apjo.2023.100030. Epub 2023 Dec 1. PMID: 38233300.

 

  1. Brar AS, Parameswarappa DC, Takkar B, Narayanan R, Jalali S, Mandal S,

Fujinami K, Padhy SK. Gene Therapy for Inherited Retinal Diseases: From

Laboratory Bench to Patient Bedside and Beyond. Ophthalmol Ther. 2024

Jan;13(1):21-50. doi: 10.1007/s40123-023-00862-2. Epub 2023 Dec 19. PMID:

38113023; PMCID: PMC10776519.

 

  1. Wang SW, Igarashi-Yokoi T, Mochida S, Fujinami K, Ohno-Matsui K. PREVALENCE

AND CLINICAL FEATURES OF RADIAL FUNDUS AUTOFLUORESCENCE IN HIGH MYOPIC WOMEN.

Retina. 2024 Mar 1;44(3):446-454. doi: 10.1097/IAE.0000000000003981. PMID:37948743.

 

  1. Fujinami K§, Waheed N, Laich Y, Yang P, Fujinami-Yokokawa Y, Higgins JJ, Lu

JT, Curtiss D, Clary C, Michaelides M. Stargardt macular dystrophy and

therapeutic approaches. Br J Ophthalmol. 2024 Mar 20;108(4):495-505. doi:

10.1136/bjo-2022-323071. PMID: 37940365; PMCID: PMC10958310.

 

  1. Fujinami-Yokokawa Y, Yang L, Joo K, Tsunoda K, Liu X, Kondo M, Ahn SJ, Li H,

Park KH, Tachimori H, Miyata H, Woo SJ, Sui R, Fujinami K§. Occult Macular

Dysfunction Syndrome: Identification of Multiple Pathologies in a Clinical

Spectrum of Macular Dysfunction with Normal Fundus in East Asian Patients: EAOMD

Report No. 5. Genes (Basel). 2023 Sep 26;14(10):1869. doi:

10.3390/genes14101869. PMID: 37895218; PMCID: PMC10606510.

 

  1. de Guimaraes TAC, Georgiou M, Robson AG, Fujinami K, Vincent A, Nasser F,

Khateb S, Mahroo OA, Pontikos N, Vargas ME, Thiadens AAHJ, Carvalho ER, Nguyen

XT, Arno G, Fujinami-Yokokawa Y, Liu X, Tsunoda K, Hayashi T, Jiménez-Rolando B,

Martin-Merida MI, Avila-Fernandez A, Salas EC, Garcia-Sandoval B, Ayuso C,

Sharon D, Kohl S, Huckfeldt RM, Banin E, Pennesi ME, Khan AO, Wissinger B,

Webster AR, Heon E, Boon CJF, Zrenner E, Michaelides M. <i>KCNV2</i>-associated

retinopathy: genotype-phenotype correlations - <i>KCNV2</i> study group report

3. Br J Ophthalmol. 2024 Jul 23;108(8):1137-1144. doi: 10.1136/bjo-2023-323640.

PMID: 37852740; PMCID: PMC11287651.

 

  1. Georgiou M, Fujinami K, Robson AG, Fujinami-Yokokawa Y, Shakarchi AF, Ji MH,

Uwaydat SH, Kim A, Kolesnikova M, Arno G, Pontikos N, Mahroo OA, Tsang SH,

Webster AR, Michaelides M. RBP3-Retinopathy-Inherited High Myopia and Retinal

Dystrophy: Genetic Characterization, Natural History, and Deep Phenotyping. Am J

Ophthalmol. 2024 Feb;258:119-129. doi: 10.1016/j.ajo.2023.09.025. Epub 2023 Oct

7. PMID: 37806543; PMCID: PMC11139644.

 

  1. Matsushita I, Izumi H, Ueno S, Hayashi T, Fujinami K, Tsunoda K, Iwata T,

Kiuchi Y, Kondo H. Functional Characteristics of Diverse <i>PAX6</i> Mutations

Associated with Isolated Foveal Hypoplasia. Genes (Basel). 2023 Jul

21;14(7):1483. doi: 10.3390/genes14071483. PMID: 37510387; PMCID: PMC10379490.

 

  1. Daich Varela M, Duignan ES, De Silva SR, Ba-Abbad R, Fujinami-Yokokawa Y,

Leo S, Fujinami K, Mahroo OA, Robson AG, Webster AR, Michaelides M. CERKL-

Associated Retinal Dystrophy: Genetics, Phenotype, and Natural History.

Ophthalmol Retina. 2023 Oct;7(10):918-931. doi: 10.1016/j.oret.2023.06.007. Epub

2023 Jun 17. PMID: 37331655; PMCID: PMC11108804.

 

  1. Nguyen Q, Woof W, Kabiri N, Sen S, Daich Varela M, Cabral De Guimaraes TA,

Shah M, Sumodhee D, Moghul I, Al-Khuzaei S, Liu Y, Hollyhead C, Tailor B, Lobo

L, Veal C, Archer S, Furman J, Arno G, Gomes M, Fujinami K, Madhusudhan S,

Mahroo OA, Webster AR, Balaskas K, Downes SM, Michaelides M, Pontikos N;

Eye2Gene Patient Advisory Group. Can artificial intelligence accelerate the

diagnosis of inherited retinal diseases? Protocol for a data-only retrospective

cohort study (Eye2Gene). BMJ Open. 2023 Mar 20;13(3):e071043. doi:

10.1136/bmjopen-2022-071043. PMID: 36940949; PMCID: PMC10030964.

 

  1. Kondo M, Fujinami K, Horiguchi M; Local Organizers of ISCEV in Kyoto 2023.

60th annual symposium of the international society for clinical

electrophysiology of vision (ISCEV 2023 Kyoto). Doc Ophthalmol. 2023

Mar;146(Suppl 1):1-2. doi: 10.1007/s10633-023-09926-x. PMID: 36856890.

 

  1. Onyango O, Mureithi M, Kithinji D, Jaoko W, Fujinami K. Challenges and

Opportunities in the Genetic Analysis of Inherited Retinal Dystrophies in

Africa, a Literature Review. J Pers Med. 2023 Jan 29;13(2):239. doi:

10.3390/jpm13020239. PMID: 36836473; PMCID: PMC9964248.

 

  1. Strauss RW, Ho A, Jha A, Fujinami K, Michaelides M, Cideciyan AV, Audo I,

Birch DG, Sadda S, Ip M, West S, Schönbach EM, Kong X, Scholl HPN; Progstar

Study Group. Progression of Stargardt Disease as Determined by Fundus

Autofluorescence Over a 24-Month Period (ProgStar Report No. 17). Am J

Ophthalmol. 2023 Jun;250:157-170. doi: 10.1016/j.ajo.2023.02.003. Epub 2023 Feb

9. PMID: 36764427.

 

  1. Mizumoto K, Kato K, Fujinami K, Sugita T, Sugita I, Hattori A, Saitoh S,

Ueno S, Tsunoda K, Iwata T, Kondo M. A Japanese boy with Bardet-Biedl syndrome

caused by a novel homozygous variant in the ARL6 gene who was initially

diagnosed with retinitis punctata albescens: A case report. Medicine

(Baltimore). 2022 Dec 16;101(50):e32161. doi: 10.1097/MD.0000000000032161. PMID:

36550847; PMCID: PMC9771268.

 

  1. Suga A, Yoshitake K, Minematsu N, Tsunoda K, Fujinami K, Miyake Y, Kuniyoshi

K, Hayashi T, Mizobuchi K, Ueno S, Terasaki H, Kominami T, Nao-I N, Mawatari G,

Mizota A, Shinoda K, Kondo M, Kato K, Sekiryu T, Nakamura M, Kusuhara S,

Yamamoto H, Yamamoto S, Mochizuki K, Kondo H, Matsushita I, Kameya S, Fukuchi T,

Hatase T, Horiguchi M, Shimada Y, Tanikawa A, Yamamoto S, Miura G, Ito N,

Murakami A, Fujimaki T, Hotta Y, Tanaka K, Iwata T. Genetic characterization of

1210 Japanese pedigrees with inherited retinal diseases by whole-exome

sequencing. Hum Mutat. 2022 Dec;43(12):2251-2264. doi: 10.1002/humu.24492. Epub

2022 Nov 7. PMID: 36284460.

 

  1. Daich Varela M, Georgiou M, Alswaiti Y, Kabbani J, Fujinami K, Fujinami-

Yokokawa Y, Khoda S, Mahroo OA, Robson AG, Webster AR, AlTalbishi A, Michaelides

M. CRB1-Associated Retinal Dystrophies: Genetics, Clinical Characteristics, and

Natural History. Am J Ophthalmol. 2023 Feb;246:107-121. doi:

10.1016/j.ajo.2022.09.002. Epub 2022 Sep 12. PMID: 36099972; PMCID: PMC10555856.

 

  1. Berry V*, Fujinami K*, Mochizuki K, Iwata T, Pontikos N, Quinlan RA,

Michaelides M. A recurrent variant in <i>LIM2</i> causes an isolated congenital

sutural/lamellar cataract in a Japanese family. Ophthalmic Genet. 2022

Oct;43(5):622-626. doi: 10.1080/13816810.2022.2090010. Epub 2022 Jun 23. PMID:

35736209; PMCID: PMC9612932.

 

  1. Kayazawa T, Kuniyoshi K, Hatsukawa Y, Fujinami K, Yoshitake K, Tsunoda K,

Shimojo H, Iwata T, Kusaka S. Clinical course of a Japanese girl with Leber

congenital amaurosis associated with a novel nonsense pathogenic variant in

<i>NMNAT1</i>: a case report and mini review. Ophthalmic Genet. 2022

Jun;43(3):400-408. doi: 10.1080/13816810.2021.2023195. Epub 2022 Jan 13. PMID:

35026968.

 

  1. Ahn SJ, Yang L, Tsunoda K, Kondo M, Fujinami-Yokokawa Y, Nakamura N, Iwata

T, Kim MS, Mun Y, Park JY, Joo K, Park KH, Miyake Y, Sui R, Fujinami K§, Woo SJ§;

East Asia Inherited Retinal Disease Society Study Group. Visual Field

Characteristics in East Asian Patients With Occult Macular Dystrophy (Miyake

Disease): EAOMD Report No. 3. Invest Ophthalmol Vis Sci. 2022 Jan 3;63(1):12.

doi: 10.1167/iovs.63.1.12. PMID: 34994768; PMCID: PMC8762684.

 

  1. Yamazawa K, Shimizu K, Ohashi H, Haruna H, Inoue S, Murakami H, Matsunaga T,

Iwata T, Tsunoda K, Fujinami K§. A Japanese boy with double diagnoses of

2p15p16.1 microdeletion syndrome and RP2-associated retinal disorder. Hum Genome

Var. 2021 Dec 17;8(1):46. doi: 10.1038/s41439-021-00178-2. PMID: 34921139;

PMCID: PMC8683409.

 

  1. Maile H, Li JO, Gore D, Leucci M, Mulholland P, Hau S, Szabo A, Moghul I,

Balaskas K, Fujinami K, Hysi P, Davidson A, Liskova P, Hardcastle A, Tuft S,

Pontikos N. Machine Learning Algorithms to Detect Subclinical Keratoconus:

Systematic Review. JMIR Med Inform. 2021 Dec 13;9(12):e27363. doi:

10.2196/27363. PMID: 34898463; PMCID: PMC8713097.

 

  1. Oishi A*, Fujinami K*, Mawatari G, Naoi N, Ikeda Y, Ueno S, Kuniyoshi K,

Hayashi T, Kondo H, Mizota A, Shinoda K, Kusuhara S, Nakamura M, Iwata T,

Tsujikawa A, Tsunoda K. Genetic and Phenotypic Landscape of

<i>PRPH2</i>-Associated Retinal Dystrophy in Japan. Genes (Basel). 2021 Nov

18;12(11):1817. doi: 10.3390/genes12111817. PMID: 34828423; PMCID: PMC8624169.

 

  1. Georgiou M*, Finocchio L*, Fujinami K*, Fujinami-Yokokawa Y, Virgili G, Mahroo

OA, Webster AR, Michaelides M. X-Linked Retinoschisis: Deep Phenotyping and

Genetic Characterization. Ophthalmology. 2022 May;129(5):542-551. doi:

10.1016/j.ophtha.2021.11.019. Epub 2021 Nov 23. PMID: 34822951.

 

  1. Akiyama K, Fujinami K, Watanabe K, Matsuki T, Tsunoda K, Noda T. RETINAL

SURFACE WRINKLING AS AN INDICATOR FOR INTERNAL LIMITING MEMBRANE PEELING DURING

VITRECTOMY FOR RETINAL DETACHMENT. Retina. 2021 Aug 1;41(8):1618-1626. doi:

10.1097/IAE.0000000000003094. PMID: 34397965; PMCID: PMC8297538.

 

  1. Schönbach EM, Strauss RW, Cattaneo MEGV, Fujinami K, Birch DG, Cideciyan AV,

Sunness JS, Zrenner E, Sadda SR, Scholl HPN; ProgStar Study Group. Longitudinal

Changes of Fixation Stability and Location Within 24 Months in Stargardt

Disease: ProgStar Report No. 16. Am J Ophthalmol. 2022 Jan;233:78-89. doi:

10.1016/j.ajo.2021.07.013. Epub 2021 Jul 21. PMID: 34298008.

 

  1. Ozawa H, Ueno S, Ohno-Tanaka A, Sakai T, Hashiguchi M, Shimizu M, Fujinami

K, Ahn SJ, Kondo M, Browning DJ, Shinoda K, Yokogawa N. Ocular findings in

Japanese patients with hydroxychloroquine retinopathy developing within 3 years

of treatment. Jpn J Ophthalmol. 2021 Jul;65(4):472-481. doi:

10.1007/s10384-021-00841-9. Epub 2021 May 20. PMID: 34014447.

 

37: Schönbach EM, Janeschitz-Kriegl L, Strauss RW, Cattaneo MEGV, Fujinami K,

Birch DG, Cideciyan AV, Sunness JS, Weleber RG, Ip MS, Sadda SR, Scholl HPN;

ProgStar Study Group. The Progression of Stargardt Disease Using Volumetric Hill

of Vision Analyses Over 24 Months: ProgStar Report No.15. Am J Ophthalmol. 2021

Oct;230:123-133. doi: 10.1016/j.ajo.2021.04.015. Epub 2021 May 2. PMID:

33951446.

 

38: Georgiou M, Fujinami K, Michaelides M. Retinal imaging in inherited retinal

diseases. Ann Eye Sci. 2020 Sep;5:25. doi: 10.21037/aes-20-81. Epub 2020 Sep 15.

PMID: 33928237; PMCID: PMC8081382.

 

39: Fujinami-Yokokawa Y, Ninomiya H, Liu X, Yang L, Pontikos N, Yoshitake K,

Iwata T, Sato Y, Hashimoto T, Tsunoda K, Miyata H, Fujinami K; Japan Eye

Genetics Study (JEGC) Group. Prediction of causative genes in inherited retinal

disorder from fundus photography and autofluorescence imaging using deep

learning techniques. Br J Ophthalmol. 2021 Sep;105(9):1272-1279. doi:

10.1136/bjophthalmol-2020-318544. Epub 2021 Apr 20. PMID: 33879469; PMCID:

PMC8380883.

 

40: Yamada Y, Fujinami K, Eguchi T, Takefuji H, Mori N. Multisystem Inflammatory

Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan. Emerg Infect Dis.

2021 Jun;27(6):1740-1742. doi: 10.3201/eid2706.210728. Epub 2021 Apr 6. PMID:

33821784; PMCID: PMC8153873.

 

41: Georgiou M, Fujinami K, Vincent A, Nasser F, Khateb S, Vargas ME, Thiadens

AAHJ, de Carvalho ER, Nguyen XT, De Guimarães TAC, Robson AG, Mahroo OA,

Pontikos N, Arno G, Fujinami-Yokokawa Y, Leo SM, Liu X, Tsunoda K, Hayashi T,

Jimenez-Rolando B, Martin-Merida MI, Avila-Fernandez A, Carreño E, Garcia-

Sandoval B, Ayuso C, Sharon D, Kohl S, Huckfeldt RM, Boon CJF, Banin E, Pennesi

ME, Wissinger B, Webster AR, Héon E, Khan AO, Zrenner E, Michaelides M.

KCNV2-Associated Retinopathy: Detailed Retinal Phenotype and Structural

Endpoints-KCNV2 Study Group Report 2. Am J Ophthalmol. 2021 Oct;230:1-11. doi:

10.1016/j.ajo.2021.03.004. Epub 2021 Mar 15. PMID: 33737031; PMCID: PMC8710866.

 

42: Georgiou M, Fujinami K, Michaelides M. Inherited retinal diseases:

Therapeutics, clinical trials and end points-A review. Clin Exp Ophthalmol. 2021

Apr;49(3):270-288. doi: 10.1111/ceo.13917. Epub 2021 Mar 20. PMID: 33686777.

 

43: Murakami Y, Koyanagi Y, Fukushima M, Yoshimura M, Fujiwara K, Akiyama M,

Momozawa Y, Ueno S, Terasaki H, Oishi A, Miyata M, Ikeda H, Tsujikawa A,

Mizobuchi K, Hayashi T, Fujinami K, Tsunoda K, Park JY, Han J, Kim M, Lee CS,

Kim SJ, Park TK, Joo K, Woo SJ, Ikeda Y, Sonoda KH. Genotype and Long-term

Clinical Course of Bietti Crystalline Dystrophy in Korean and Japanese Patients.

Ophthalmol Retina. 2021 Dec;5(12):1269-1279. doi: 10.1016/j.oret.2021.02.009.

Epub 2021 Feb 23. PMID: 33636399.

 

44: Lie H, Wang G, Liu X, Meng X, Long Y, Ren J, Yang L, Fujinami-Yokokawa Y,

Kurihara T, Tsubota K, Fujinami K, Li S. Long-term follow-up of a Chinese

patient with <i>KCNV2</i>-retinopathy. Ophthalmic Genet. 2021 Apr;42(2):144-149.

doi: 10.1080/13816810.2020.1861307. Epub 2020 Dec 29. PMID: 33372566.

 

45: Georgiou M, Robson AG, Fujinami K, Leo SM, Vincent A, Nasser F, Cabral De

Guimarães TA, Khateb S, Pontikos N, Fujinami-Yokokawa Y, Liu X, Tsunoda K,

Hayashi T, Vargas ME, Thiadens AAHJ, de Carvalho ER, Nguyen XT, Arno G, Mahroo

OA, Martin-Merida MI, Jimenez-Rolando B, Gordo G, Carreño E, Ayuso C, Sharon D,

Kohl S, Huckfeldt RM, Wissinger B, Boon CJF, Banin E, Pennesi ME, Khan AO,

Webster AR, Zrenner E, Héon E, Michaelides M. KCNV2-Associated Retinopathy:

Genetics, Electrophysiology, and Clinical Course-KCNV2 Study Group Report 1. Am

J Ophthalmol. 2021 May;225:95-107. doi: 10.1016/j.ajo.2020.11.022. Epub 2020 Dec

11. PMID: 33309813; PMCID: PMC8186730.

 

46: Poulter JA, Gravett MSC, Taylor RL, Fujinami K, De Zaeytijd J, Bellingham J,

Rehman AU, Hayashi T, Kondo M, Rehman A, Ansar M, Donnelly D, Toomes C, Ali M;

UK Inherited Retinal Disease Consortium, Genomics England Research Consortium;

De Baere E, Leroy BP, Davies NP, Henderson RH, Webster AR, Rivolta C, Zeitz C,

Mahroo OA, Arno G, Black GCM, McKibbin M, Harris SA, Khan KN, Inglehearn CF. New

variants and in silico analyses in GRK1 associated Oguchi disease. Hum Mutat.

2021 Feb;42(2):164-176. doi: 10.1002/humu.24140. Epub 2020 Nov 30. PMID:

33252155; PMCID: PMC7898643.

 

47: Hirakata T, Fujinami K, Saito W, Kanda A, Hirakata A, Ishida S, Murakami A,

Tsunoda K, Miyake Y. Acute unilateral inner retinal dysfunction with

photophobia: importance of electrodiagnosis. Jpn J Ophthalmol. 2021

Jan;65(1):42-53. doi: 10.1007/s10384-020-00780-x. Epub 2020 Nov 12. PMID:

33180210.

 

48: Li SY, Fujinami K, Crewther SG, Long YL, Lie HX, Yin ZQ. Fish oil

supplementation and repeated macular hemorrhage without choroidal

neovascularization: A case report. SAGE Open Med Case Rep. 2020 Sep

15;8:2050313X20952974. doi: 10.1177/2050313X20952974. PMID: 32974025; PMCID:

PMC7495924.

 

49: Fujinami K, Liu X, Ueno S, Mizota A, Shinoda K, Kuniyoshi K, Fujinami-

Yokokawa Y, Yang L, Arno G, Pontikos N, Kameya S, Kominami T, Terasaki H,

Sakuramoto H, Nakamura N, Kurihara T, Tsubota K, Miyake Y, Yoshiake K, Iwata T,

Tsunoda K; Japan Eye Genetics Consortium Study Group. RP2-associated retinal

disorder in a Japanese cohort: Report of novel variants and a literature review,

identifying a genotype-phenotype association. Am J Med Genet C Semin Med Genet.

2020 Sep;184(3):675-693. doi: 10.1002/ajmg.c.31830. Epub 2020 Sep 1. PMID:

32875684.

 

50: Liu X, Meng X, Yang L, Long Y, Fujinami-Yokokawa Y, Ren J, Kurihara T,

Tsubota K, Tsunoda K, Fujinami K, Li S; East Asia Inherited Retinal Disease

Society Study Group. Clinical and genetic characteristics of Stargardt disease

in a large Western China cohort: Report 1. Am J Med Genet C Semin Med Genet.

2020 Sep;184(3):694-707. doi: 10.1002/ajmg.c.31838. Epub 2020 Aug 26. PMID:

32845068.

 

51: Liu X, Fujinami K, Kuniyoshi K, Kondo M, Ueno S, Hayashi T, Mochizuki K,

Kameya S, Yang L, Fujinami-Yokokawa Y, Arno G, Pontikos N, Sakuramoto H,

Kominami T, Terasaki H, Katagiri S, Mizobuchi K, Nakamura N, Yoshitake K, Miyake

Y, Li S, Kurihara T, Tsubota K, Iwata T, Tsunoda K; Japan Eye Genetics

Consortium. Clinical and Genetic Characteristics of 15 Affected Patients From 12

Japanese Families with <i>GUCY2D</i>-Associated Retinal Disorder. Transl Vis Sci

Technol. 2020 May 11;9(6):2. doi: 10.1167/tvst.9.6.2. PMID: 32821499; PMCID:

PMC7408927.

 

52: Fujinami K, Oishi A, Yang L, Arno G, Pontikos N, Yoshitake K, Fujinami-

Yokokawa Y, Liu X, Hayashi T, Katagiri S, Mizobuchi K, Mizota A, Shinoda K,

Nakamura N, Kurihara T, Tsubota K, Miyake Y, Iwata T, Tsujikawa A, Tsunoda K;

Japan Eye Genetics Consortium study group. Clinical and genetic characteristics

of 10 Japanese patients with PROM1-associated retinal disorder: A report of the

phenotype spectrum and a literature review in the Japanese population. Am J Med

Genet C Semin Med Genet. 2020 Sep;184(3):656-674. doi: 10.1002/ajmg.c.31826.

Epub 2020 Aug 20. PMID: 32820593.

 

53: Runhart EH, Khan M, Cornelis SS, Roosing S, Del Pozo-Valero M, Lamey TM,

Liskova P, Roberts L, Stöhr H, Klaver CCW, Hoyng CB, Cremers FPM, Dhaenens CM;

Disease Consortium Study Group. Association of Sex With Frequent and Mild ABCA4

Alleles in Stargardt Disease. JAMA Ophthalmol. 2020 Oct 1;138(10):1035-1042.

doi: 10.1001/jamaophthalmol.2020.2990. Erratum in: JAMA Ophthalmol. 2021 Apr

1;139(4):489. doi: 10.1001/jamaophthalmol.2021.0124. PMID: 32815999; PMCID:

PMC7441467.

 

54: Georgiou M, Grewal PS, Narayan A, Alser M, Ali N, Fujinami K, Webster AR,

Michaelides M. Sector Retinitis Pigmentosa: Extending the Molecular Genetics

Basis and Elucidating the Natural History. Am J Ophthalmol. 2021

Jan;221:299-310. doi: 10.1016/j.ajo.2020.08.004. Epub 2020 Aug 12. PMID:

32795431; PMCID: PMC7772805.

 

55: Yang L, Joo K, Tsunoda K, Kondo M, Fujinami-Yokokawa Y, Arno G, Pontikos N,

Liu X, Nakamura N, Kurihara T, Tsubota K, Iwata T, Li H, Zou X, Wu S, Sun Z, Ahn

SJ, Kim MS, Mun YS, Park KH, Robson AG, Miyake Y, Woo SJ, Sui R, Fujinami K;

East Asia Inherited Retinal Disease Society Study Group. Spatial Functional

Characteristics of East Asian Patients With Occult Macular Dystrophy (Miyake

Disease); EAOMD Report No. 2. Am J Ophthalmol. 2021 Jan;221:169-180. doi:

10.1016/j.ajo.2020.07.025. Epub 2020 Jul 21. PMID: 32707201.

 

56: Hirose A, Katagiri S, Hayashi T, Matsuura T, Nagai N, Fujinami K, Iwata T,

Tsunoda K. Progress of macular atrophy during 30 months' follow-up in a patient

with spinocerebellar ataxia type1 (SCA1). Doc Ophthalmol. 2021 Feb;142(1):87-98.

doi: 10.1007/s10633-020-09782-z. Epub 2020 Jul 9. PMID: 32648025.

 

57: Fujinami-Yokokawa Y, Fujinami K, Kuniyoshi K, Hayashi T, Ueno S, Mizota A,

Shinoda K, Arno G, Pontikos N, Yang L, Liu X, Sakuramoto H, Katagiri S,

Mizobuchi K, Kominami T, Terasaki H, Nakamura N, Kameya S, Yoshitake K, Miyake

Y, Kurihara T, Tsubota K, Miyata H, Iwata T, Tsunoda K; Japan Eye Genetics

Consortium. Clinical and Genetic Characteristics of 18 Patients from 13 Japanese

Families with CRX-associated retinal disorder: Identification of Genotype-

phenotype Association. Sci Rep. 2020 Jun 12;10(1):9531. doi:

10.1038/s41598-020-65737-z. PMID: 32533067; PMCID: PMC7293272.

 

58: Mizobuchi K, Hayashi T, Yoshitake K, Fujinami K, Tachibana T, Tsunoda K,

Iwata T, Nakano T. Novel homozygous CLN3 missense variant in isolated retinal

dystrophy: A case report and electron microscopic findings. Mol Genet Genomic

Med. 2020 Aug;8(8):e1308. doi: 10.1002/mgg3.1308. Epub 2020 May 22. PMID:

32441891; PMCID: PMC7434607.

 

59: Liu X, Gao L, Wang G, Long Y, Ren J, Fujinami K, Meng X, Li S. Oguchi

disease caused by a homozygous novel SAG splicing alteration associated with the

multiple evanescent white dot syndrome: A 15-month follow-up. Doc Ophthalmol.

2020 Dec;141(3):217-226. doi: 10.1007/s10633-020-09766-z. Epub 2020 Apr 24.

PMID: 32333190.

 

60: Khan M, Cornelis SS, Pozo-Valero MD, Whelan L, Runhart EH, Mishra K, Bults

F, AlSwaiti Y, AlTalbishi A, De Baere E, Banfi S, Banin E, Bauwens M, Ben-Yosef

T, Boon CJF, van den Born LI, Defoort S, Devos A, Dockery A, Dudakova L, Fakin

A, Farrar GJ, Sallum JMF, Fujinami K, Gilissen C, Glavač D, Gorin MB, Greenberg

J, Hayashi T, Hettinga YM, Hoischen A, Hoyng CB, Hufendiek K, Jägle H, Kamakari

S, Karali M, Kellner U, Klaver CCW, Kousal B, Lamey TM, MacDonald IM, Matynia A,

McLaren TL, Mena MD, Meunier I, Miller R, Newman H, Ntozini B, Oldak M, Pieterse

M, Podhajcer OL, Puech B, Ramesar R, Rüther K, Salameh M, Salles MV, Sharon D,

Simonelli F, Spital G, Steehouwer M, Szaflik JP, Thompson JA, Thuillier C,

Tracewska AM, van Zweeden M, Vincent AL, Zanlonghi X, Liskova P, Stöhr H, Roach

JN, Ayuso C, Roberts L, Weber BHF, Dhaenens CM, Cremers FPM. Resolving the dark

matter of ABCA4 for 1054 Stargardt disease probands through integrated genomics

and transcriptomics. Genet Med. 2020 Jul;22(7):1235-1246. doi:

10.1038/s41436-020-0787-4. Epub 2020 Apr 20. PMID: 32307445.

 

61: Pontikos N, Murphy C, Moghul I, Arno G, Fujinami K, Fujinami Y, Sumodhee D,

Downes S, Webster A, Yu J; UK Inherited Retinal Dystrophy Consortium, Phenopolis

Consortium. Phenogenon: Gene to phenotype associations for rare genetic

diseases. PLoS One. 2020 Apr 9;15(4):e0230587. doi:

10.1371/journal.pone.0230587. PMID: 32271766; PMCID: PMC7144978.

 

62: Katagiri S, Hayashi T, Nakamura M, Mizobuchi K, Gekka T, Komori S, Ueno S,

Terasaki H, Sakuramoto H, Kuniyoshi K, Kusaka S, Nagashima R, Kondo M, Fujinami

K, Tsunoda K, Matsuura T, Kondo H, Yoshitake K, Iwata T, Nakano T. RDH5-Related

Fundus Albipunctatus in a Large Japanese Cohort. Invest Ophthalmol Vis Sci. 2020

Mar 9;61(3):53. doi: 10.1167/iovs.61.3.53. PMID: 32232344; PMCID: PMC7401827.

 

63: Schönbach EM, Strauss RW, Ibrahim MA, Janes JL, Birch DG, Cideciyan AV,

Sunness JS, Muñoz B, Ip MS, Sadda SR, Scholl HPN; ProgStar Study Group. Faster

Sensitivity Loss around Dense Scotomas than for Overall Macular Sensitivity in

Stargardt Disease: ProgStar Report No. 14. Am J Ophthalmol. 2020

Aug;216:219-225. doi: 10.1016/j.ajo.2020.03.020. Epub 2020 Mar 25. PMID:

32222369.

 

64: Yang L, Fujinami K, Ueno S, Kuniyoshi K, Hayashi T, Kondo M, Mizota A, Naoi

N, Shinoda K, Kameya S, Fujinami-Yokokawa Y, Liu X, Arno G, Pontikos N, Kominami

T, Terasaki H, Sakuramoto H, Katagiri S, Mizobuchi K, Nakamura N, Mawatari G,

Kurihara T, Tsubota K, Miyake Y, Yoshitake K, Iwata T, Tsunoda K; JEGC study

group. Genetic Spectrum of EYS-associated Retinal Disease in a Large Japanese

Cohort: Identification of Disease-associated Variants with Relatively High

Allele Frequency. Sci Rep. 2020 Mar 26;10(1):5497. doi:

10.1038/s41598-020-62119-3. PMID: 32218477; PMCID: PMC7099090.

 

65: Berry V, Georgiou M, Fujinami K, Quinlan R, Moore A, Michaelides M.

Inherited cataracts: molecular genetics, clinical features, disease mechanisms

and novel therapeutic approaches. Br J Ophthalmol. 2020 Oct;104(10):1331-1337.

doi: 10.1136/bjophthalmol-2019-315282. Epub 2020 Mar 25. PMID: 32217542.

 

66: Kuniyoshi K, Hayashi T, Kameya S, Katagiri S, Mizobuchi K, Tachibana T,

Kubota D, Sakuramoto H, Tsunoda K, Fujinami K, Yoshitake K, Iwata T, Nakano T,

Kusaka S. Clinical Course and Electron Microscopic Findings in Lymphocytes of

Patients with <i>DRAM2</i>-Associated Retinopathy. Int J Mol Sci. 2020 Feb

16;21(4):1331. doi: 10.3390/ijms21041331. PMID: 32079136; PMCID: PMC7072995.

 

67: Mawatari G, Fujinami K, Liu X, Yang L, Fujinami-Yokokawa Y, Komori S, Ueno

S, Terasaki H, Katagiri S, Hayashi T, Kuniyoshi K, Miyake Y, Tsunoda K,

Yoshitake K, Iwata T, Nao-I N; JEGC study group. Correction to: Clinical and

genetic characteristics of 14 patients from 13 Japanese families with

<i>RPGR</i>-associated retinal disorder: report of eight novel variants. Hum

Genome Var. 2020 Feb 10;7:3. doi: 10.1038/s41439-019-0086-2. Erratum for: Hum

Genome Var. 2019 Aug 2;6:34. doi: 10.1038/s41439-019-0065-7. PMID: 32047640;

PMCID: PMC7008114.

 

68: Georgiou M, Kane T, Tanna P, Bouzia Z, Singh N, Kalitzeos A, Strauss RW,

Fujinami K, Michaelides M. Prospective Cohort Study of Childhood-Onset Stargardt

Disease: Fundus Autofluorescence Imaging, Progression, Comparison with Adult-

Onset Disease, and Disease Symmetry. Am J Ophthalmol. 2020 Mar;211:159-175. doi:

10.1016/j.ajo.2019.11.008. Epub 2019 Dec 6. PMID: 31812472; PMCID: PMC7082771.

 

69: Mizobuchi K, Hayashi T, Katagiri S, Yoshitake K, Fujinami K, Yang L,

Kuniyoshi K, Shinoda K, Machida S, Kondo M, Ueno S, Terasaki H, Matsuura T,

Tsunoda K, Iwata T, Nakano T. Characterization of GUCA1A-associated dominant

cone/cone-rod dystrophy: low prevalence among Japanese patients with inherited

retinal dystrophies. Sci Rep. 2019 Nov 14;9(1):16851. doi:

10.1038/s41598-019-52660-1. PMID: 31728034; PMCID: PMC6856191.

 

70: Nakamura N, Tsunoda K, Mizuno Y, Usui T, Hatase T, Ueno S, Kuniyoshi K,

Hayashi T, Katagiri S, Kondo M, Kameya S, Yoshitake K, Fujinami K, Iwata T,

Miyake Y. Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence

Tomographic Findings. Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4691-4700.

doi: 10.1167/iovs.19-27486. PMID: 31725168.

 

71: Bouzia Z, Georgiou M, Hull S, Robson AG, Fujinami K, Rotsos T, Pontikos N,

Arno G, Webster AR, Hardcastle AJ, Fiorentino A, Michaelides M.

GUCY2D-Associated Leber Congenital Amaurosis: A Retrospective Natural History

Study in Preparation for Trials of Novel Therapies. Am J Ophthalmol. 2020

Feb;210:59-70. doi: 10.1016/j.ajo.2019.10.019. Epub 2019 Nov 5. PMID: 31704230;

PMCID: PMC7013380.

 

72: Maeda-Katahira A, Nakamura N, Hayashi T, Katagiri S, Shimizu S, Ohde H,

Matsunaga T, Kaga K, Nakano T, Kameya S, Matsuura T, Fujinami K, Iwata T,

Tsunoda K. Autosomal dominant optic atrophy with <i>OPA1</i> gene mutations

accompanied by auditory neuropathy and other systemic complications in a

Japanese cohort. Mol Vis. 2019 Oct 5;25:559-573. PMID: 31673222; PMCID:

PMC6798706.

 

73: Mawatari G, Fujinami K, Liu X, Yang L, Yokokawa YF, Komori S, Ueno S,

Terasaki H, Katagiri S, Hayashi T, Kuniyoshi K, Miyake Y, Tsunoda K, Yoshitake

K, Iwata T, Nao-I N; JEGC study group. Clinical and genetic characteristics of

14 patients from 13 Japanese families with <i>RPGR</i>-associated retinal

disorder: report of eight novel variants. Hum Genome Var. 2019 Aug 2;6:34. doi:

10.1038/s41439-019-0065-7. Erratum in: Hum Genome Var. 2020 Feb 10;7:3. doi:

10.1038/s41439-019-0086-2. PMID: 31645972; PMCID: PMC6804603.

 

74: Kameya S, Fujinami K, Ueno S, Hayashi T, Kuniyoshi K, Ideta R, Kikuchi S,

Kubota D, Yoshitake K, Katagiri S, Sakuramoto H, Kominami T, Terasaki H, Yang L,

Fujinami-Yokokawa Y, Liu X, Arno G, Pontikos N, Miyake Y, Iwata T, Tsunoda K;

Japan Eye Genetics Consortium. Phenotypical Characteristics of POC1B-Associated

Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic

Appearance. Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3432-3446. doi:

10.1167/iovs.19-26650. PMID: 31390656.

 

75: Tsunoda K, Fujinami K, Yoshitake K, Iwata T. Late-onset night blindness with

peripheral flecks accompanied by progressive trickle-like macular degeneration.

Doc Ophthalmol. 2019 Dec;139(3):171-184. doi: 10.1007/s10633-019-09705-7. Epub

2019 Jul 8. PMID: 31286363.

 

76: Fujinami-Yokokawa Y, Pontikos N, Yang L, Tsunoda K, Yoshitake K, Iwata T,

Miyata H, Fujinami K, Japan Eye Genetics Consortium OBO. Prediction of Causative

Genes in Inherited Retinal Disorders from Spectral-Domain Optical Coherence

Tomography Utilizing Deep Learning Techniques. J Ophthalmol. 2019 Apr

9;2019:1691064. doi: 10.1155/2019/1691064. PMID: 31093368; PMCID: PMC6481010.

 

77: Fujinami K, Yang L, Joo K, Tsunoda K, Kameya S, Hanazono G, Fujinami-

Yokokawa Y, Arno G, Kondo M, Nakamura N, Kurihara T, Tsubota K, Zou X, Li H,

Park KH, Iwata T, Miyake Y, Woo SJ, Sui R; East Asia Inherited Retinal Disease

Society study group. Clinical and Genetic Characteristics of East Asian Patients

with Occult Macular Dystrophy (Miyake Disease): East Asia Occult Macular

Dystrophy Studies Report Number 1. Ophthalmology. 2019 Oct;126(10):1432-1444.

doi: 10.1016/j.ophtha.2019.04.032. Epub 2019 Apr 25. PMID: 31028767.

 

78: Tanna P, Georgiou M, Strauss RW, Ali N, Kumaran N, Kalitzeos A, Fujinami K,

Michaelides M. Cross-Sectional and Longitudinal Assessment of the Ellipsoid Zone

in Childhood-Onset Stargardt Disease. Transl Vis Sci Technol. 2019 Mar 1;8(2):1.

doi: 10.1167/tvst.8.2.1. PMID: 30834176; PMCID: PMC6397016.

 

79: Suzuki K, Gocho K, Akeo K, Kikuchi S, Kubota D, Katagiri S, Fujinami K,

Tsunoda K, Iwata T, Yamaki K, Igarashi T, Nakano T, Takahashi H, Hayashi T,

Kameya S. High-Resolution Retinal Imaging Reveals Preserved Cone Photoreceptor

Density and Choroidal Thickness in Female Carriers of Choroideremia. Ophthalmic

Surg Lasers Imaging Retina. 2019 Feb 1;50(2):76-85. doi:

10.3928/23258160-20190129-03. PMID: 30768214.

 

80: Kondo H, Oku K, Katagiri S, Hayashi T, Nakano T, Iwata A, Kuniyoshi K,

Kusaka S, Hiyoshi A, Uchio E, Kondo M, Oishi N, Kameya S, Mizota A, Naoi N, Ueno

S, Terasaki H, Morimoto T, Iwaki M, Yoshitake K, Iejima D, Fujinami K, Tsunoda

K, Shinoda K, Iwata T. Novel mutations in the <i>RS1</i> gene in Japanese

patients with X-linked congenital retinoschisis. Hum Genome Var. 2019 Jan 8;6:3.

doi: 10.1038/s41439-018-0034-6. PMID: 30652005; PMCID: PMC6325138.

 

81: Mizobuchi K, Katagiri S, Hayashi T, Yoshitake K, Fujinami K, Kuniyoshi K,

Mishima R, Tsunoda K, Iwata T, Nakano T. Clinical findings of end-stage

retinitis pigmentosa with a homozygous <i>PDE6A</i> variant (p.R653X). Am J

Ophthalmol Case Rep. 2018 Dec 19;13:110-115. doi: 10.1016/j.ajoc.2018.12.019.

PMID: 30619975; PMCID: PMC6307093.

 

82: Ueno S, Inooka D, Meinert M, Ito Y, Tsunoda K, Fujinami K, Iwata T, Ohde H,

Terasaki H. Three cases of acute-onset bilateral photophobia. Jpn J Ophthalmol.

2019 Mar;63(2):172-180. doi: 10.1007/s10384-018-00649-0. Epub 2019 Jan 2. PMID:

30604114.

 

83: Nakanishi A, Ueno S, Hayashi T, Katagiri S, Ito Y, Kominami T, Fujinami K,

Tsunoda K, Iwata T, Terasaki H. CHANGES OF CONE PHOTORECEPTOR MOSAIC IN

AUTOSOMAL RECESSIVE BESTROPHINOPATHY. Retina. 2020 Jan;40(1):181-186. doi:

10.1097/IAE.0000000000002363. PMID: 30308565.

 

84: Ando R, Saito W, Kanda A, Kase S, Fujinami K, Sugahara M, Nakamura Y, Eguchi

S, Mori S, Noda K, Shinoda K, Ishida S. Clinical Features of Japanese Patients

With Anti-α-enolase Antibody-Positive Autoimmune Retinopathy: Novel Subtype of

Multiple Drusen. Am J Ophthalmol. 2018 Dec;196:181-196. doi:

10.1016/j.ajo.2018.08.044. Epub 2018 Sep 7. PMID: 30195891.

 

85: Kumaran N, Rubin GS, Kalitzeos A, Fujinami K, Bainbridge JWB, Weleber RG,

Michaelides M. A Cross-Sectional and Longitudinal Study of Retinal Sensitivity

in RPE65-Associated Leber Congenital Amaurosis. Invest Ophthalmol Vis Sci. 2018

Jul 2;59(8):3330-3339. doi: 10.1167/iovs.18-23873. Erratum in: Invest Ophthalmol

Vis Sci. 2018 Aug;59(10):4326. doi: 10.1167/iovs.18-23873a. PMID: 30025081;

PMCID: PMC6040235.

 

86: Akiyama K, Fujinami K, Watanabe K, Fukui M, Tsunoda K, Noda T. VALIDITY AND

EFFICACY OF INTERNAL LIMITING MEMBRANE PEELING DURING INITIAL VITRECTOMY FOR

RHEGMATOGENOUS RETINAL DETACHMENT: VISUAL OUTCOMES IN MACULA-SPARING CASES.

Retin Cases Brief Rep. 2021 Mar 1;15(2):114-119. doi:

10.1097/ICB.0000000000000758. PMID: 29944610.

 

87: Thompson DA, Fujinami K, Perlman I, Hamilton R, Robson AG. ISCEV extended

protocol for the dark-adapted red flash ERG. Doc Ophthalmol. 2018

Jun;136(3):191-197. doi: 10.1007/s10633-018-9644-z. Epub 2018 Jun 22. PMID:

29934801; PMCID: PMC6061112.

 

88: Fujinami K, Strauss RW, Chiang JP, Audo IS, Bernstein PS, Birch DG, Bomotti

SM, Cideciyan AV, Ervin AM, Marino MJ, Sahel JA, Mohand-Said S, Sunness JS,

Traboulsi EI, West S, Wojciechowski R, Zrenner E, Michaelides M, Scholl HPN;

ProgStar Study Group; ProgStar Study Group. Detailed genetic characteristics of

an international large cohort of patients with Stargardt disease: ProgStar study

report 8. Br J Ophthalmol. 2019 Mar;103(3):390-397. doi:

10.1136/bjophthalmol-2018-312064. Epub 2018 Jun 20. PMID: 29925512; PMCID:

PMC6579578.

 

89: Kong X, Fujinami K, Strauss RW, Munoz B, West SK, Cideciyan AV, Michaelides

M, Ahmed M, Ervin AM, Schönbach E, Cheetham JK, Scholl HPN; ProgStar Study

Group. Visual Acuity Change Over 24 Months and Its Association With Foveal

Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study

Report No. 10. JAMA Ophthalmol. 2018 Aug 1;136(8):920-928. doi:

10.1001/jamaophthalmol.2018.2198. PMID: 29902293; PMCID: PMC6142940.

 

90: Schönbach EM, Strauss RW, Kong X, Muñoz B, Ibrahim MA, Sunness JS, Birch DG,

Hahn GA, Nasser F, Zrenner E, Sadda SR, West SK, Scholl HPN; ProgStar Study

Group. Longitudinal Changes of Fixation Location and Stability Within 12 Months

in Stargardt Disease: ProgStar Report No. 12. Am J Ophthalmol. 2018

Sep;193:54-61. doi: 10.1016/j.ajo.2018.06.003. Epub 2018 Jun 8. PMID: 29890160;

PMCID: PMC7083180.

 

91: Akiyama K, Fujinami K, Watanabe K, Noda T, Miyake Y, Tsunoda K. Macular

dysfunction in patients with macula-on rhegmatogenous retinal detachments. Br J

Ophthalmol. 2019 Mar;103(3):404-409. doi: 10.1136/bjophthalmol-2018-312153. Epub

2018 Jun 1. PMID: 29858185.

 

92: Mahroo OA, Fujinami K, Moore AT, Webster AR. Retinal findings in a patient

with mutations in ABCC6 and ABCA4. Eye (Lond). 2018 Sep;32(9):1542-1543. doi:

10.1038/s41433-018-0106-3. Epub 2018 May 16. PMID: 29765157; PMCID: PMC6137180.

 

93: Khan KN, Kasilian M, Mahroo OAR, Tanna P, Kalitzeos A, Robson AG, Tsunoda K,

Iwata T, Moore AT, Fujinami K, Michaelides M. Early Patterns of Macular

Degeneration in ABCA4-Associated Retinopathy. Ophthalmology. 2018

May;125(5):735-746. doi: 10.1016/j.ophtha.2017.11.020. Epub 2018 Jan 6. PMID:

29310964; PMCID: PMC5917070.

 

94: Kominami A, Ueno S, Kominami T, Nakanishi A, Ito Y, Fujinami K, Tsunoda K,

Hayashi T, Kikuchi S, Kameya S, Iwata T, Terasaki H. Case of cone dystrophy with

normal fundus appearance associated with biallelic POC1B variants. Ophthalmic

Genet. 2018 Apr;39(2):255-262. doi: 10.1080/13816810.2017.1408846. Epub 2017 Dec

8. PMID: 29220607.

 

95: Kato Y, Hanazono G, Fujinami K, Hatase T, Kawamura Y, Iwata T, Miyake Y,

Tsunoda K. Parafoveal Photoreceptor Abnormalities in Asymptomatic Patients With

RP1L1 Mutations in Families With Occult Macular Dystrophy. Invest Ophthalmol Vis

Sci. 2017 Dec 1;58(14):6020-6029. doi: 10.1167/iovs.17-21969. PMID: 29196766.

 

96: Sasaki M, Kato Y, Fujinami K, Hirakata T, Tsunoda K, Watanabe K, Akiyama K,

Noda T. Advanced quantitative analysis of the sub-retinal pigment epithelial

space in recurrent neovascular age-related macular degeneration. PLoS One. 2017

Nov 2;12(11):e0186955. doi: 10.1371/journal.pone.0186955. PMID: 29095879; PMCID:

PMC5667874.

 

97: Fiorentino A, Fujinami K, Arno G, Robson AG, Pontikos N, Arasanz Armengol M,

Plagnol V, Hayashi T, Iwata T, Parker M, Fowler T, Rendon A, Gardner JC,

Henderson RH, Cheetham ME, Webster AR, Michaelides M, Hardcastle AJ; 100,000

Genomes Project, the Japan Eye Genetic Consortium and the UK Inherited Retinal

Dystrophy Consortium. Missense variants in the X-linked gene PRPS1 cause retinal

degeneration in females. Hum Mutat. 2018 Jan;39(1):80-91. doi:

10.1002/humu.23349. Epub 2017 Oct 17. PMID: 28967191.

 

98: Fakin A, Robson AG, Chiang JP, Fujinami K, Moore AT, Michaelides M, Holder

GE, Webster AR. The Effect on Retinal Structure and Function of 15 Specific

ABCA4 Mutations: A Detailed Examination of 82 Hemizygous Patients. Invest

Ophthalmol Vis Sci. 2016 Nov 1;57(14):5963-5973. doi: 10.1167/iovs.16-20446.

PMID: 27820952.

 

99: Tanna P, Strauss RW, Fujinami K, Michaelides M. Stargardt disease: clinical

features, molecular genetics, animal models and therapeutic options. Br J

Ophthalmol. 2017 Jan;101(1):25-30. doi: 10.1136/bjophthalmol-2016-308823. Epub

2016 Aug 4. PMID: 27491360; PMCID: PMC5256119.

 

100: Fujinami K, Kameya S, Kikuchi S, Ueno S, Kondo M, Hayashi T, Shinoda K,

Machida S, Kuniyoshi K, Kawamura Y, Akahori M, Yoshitake K, Katagiri S,

Nakanishi A, Sakuramoto H, Ozawa Y, Tsubota K, Yamaki K, Mizota A, Terasaki H,

Miyake Y, Iwata T, Tsunoda K. Novel RP1L1 Variants and Genotype-Photoreceptor

Microstructural Phenotype Associations in Cohort of Japanese Patients With

Occult Macular Dystrophy. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4837-46.

doi: 10.1167/iovs.16-19670. PMID: 27623337.

 

101: Fakin A, Robson AG, Fujinami K, Moore AT, Michaelides M, Pei-Wen Chiang J,

E Holder G, Webster AR. Phenotype and Progression of Retinal Degeneration

Associated With Nullizigosity of ABCA4. Invest Ophthalmol Vis Sci. 2016 Sep

1;57(11):4668-78. doi: 10.1167/iovs.16-19829. PMID: 27583828.

 

102: Akiyama K, Fujinami K, Watanabe K, Tsunoda K, Noda T. Internal Limiting

Membrane Peeling to Prevent Post-vitrectomy Epiretinal Membrane Development in

Retinal Detachment. Am J Ophthalmol. 2016 Nov;171:1-10. doi:

10.1016/j.ajo.2016.08.015. Epub 2016 Aug 18. PMID: 27544480.

 

103: Nakamura N, Fujinami K, Mizuno Y, Noda T, Tsunoda K. Evaluation of cone

function by a handheld non-mydriatic flicker electroretinogram device. Clin

Ophthalmol. 2016 Jun 30;10:1175-85. doi: 10.2147/OPTH.S104721. PMID: 27445454;

PMCID: PMC4936817.

 

104: Kong X, Strauss RW, Michaelides M, Cideciyan AV, Sahel JA, Muñoz B, West S,

Scholl HP; ProgStar Study Group. Visual Acuity Loss and Associated Risk Factors

in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No.

2). Ophthalmology. 2016 Sep;123(9):1887-97. doi: 10.1016/j.ophtha.2016.05.027.

Epub 2016 Jul 2. PMID: 27378015.

 

105: Hirakata T, Fujinami K, Watanabe K, Sasaki M, Noda T, Akiyama K. One-year

outcome of intravitreal aflibercept injection for age-related macular

degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent

visual improvement. Clin Ophthalmol. 2016 May 26;10:969-77. doi:

10.2147/OPTH.S101596. PMID: 27307700; PMCID: PMC4888727.

 

106: Kamoshita M, Fujinami K, Toda E, Tsubota K, Ozawa Y. Neuroprotective effect

of activated 5'-adenosine monophosphate-activated protein kinase on cone system

function during retinal inflammation. BMC Neurosci. 2016 Jun 10;17(1):32. doi:

10.1186/s12868-016-0268-5. PMID: 27287531; PMCID: PMC4902963.

 

107: Nakanishi A, Ueno S, Hayashi T, Katagiri S, Kominami T, Ito Y, Gekka T,

Masuda Y, Tsuneoka H, Shinoda K, Hirakata A, Inoue M, Fujinami K, Tsunoda K,

Iwata T, Terasaki H. Clinical and Genetic Findings of Autosomal Recessive

Bestrophinopathy in Japanese Cohort. Am J Ophthalmol. 2016 Aug;168:86-94. doi:

10.1016/j.ajo.2016.04.023. Epub 2016 May 7. PMID: 27163236.

 

108: Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG,

Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S,

Scholl HP; Progression of Stargardt Disease Study Group. The Natural History of

the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies:

Design and Baseline Characteristics: ProgStar Report No. 1. Ophthalmology. 2016

Apr;123(4):817-28. doi: 10.1016/j.ophtha.2015.12.009. Epub 2016 Jan 16. PMID:

26786511.

 

109: Mizuno M, Fujinami K, Watanabe K, Akiyama K. Macular Hole Associated with

Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage. Case Rep Ophthalmol.

2015 Sep 15;6(3):328-32. doi: 10.1159/000440679. PMID: 26483677; PMCID:

PMC4608629.

 

110: Kato Y, Tsunoda K, Fujinami K, Iwata T, Saga M, Oguchi Y. Association of

Retinal Artery and Other Inner Retinal Structures With Distribution of Tapetal-

like Reflex in Oguchi's Disease. Invest Ophthalmol Vis Sci. 2015

Apr;56(4):2162-72. doi: 10.1167/iovs.14-16198. PMID: 25744976.

 

111: Nishikawa Y, Fujinami K, Watanabe K, Noda T, Tsunoda K, Akiyama K. Clinical

course of focal choroidal excavation in Vogt-Koyanagi-Harada disease. Clin

Ophthalmol. 2014 Dec 4;8:2461-5. doi: 10.2147/OPTH.S75558. PMID: 25506207;

PMCID: PMC4259514.

 

112: Singh R, Fujinami K, Moore AT. Branch retinal artery occlusion secondary to

prepapillary arterial loop. Retin Cases Brief Rep. 2014 Spring;8(2):124-6. doi:

10.1097/ICB.0000000000000020. PMID: 25372326.

 

113: Fujinami K, Zernant J, Chana RK, Wright GA, Tsunoda K, Ozawa Y, Tsubota K,

Robson AG, Holder GE, Allikmets R, Michaelides M, Moore AT. Clinical and

molecular characteristics of childhood-onset Stargardt disease. Ophthalmology.

2015 Feb;122(2):326-34. doi: 10.1016/j.ophtha.2014.08.012. Epub 2014 Oct 12.

PMID: 25312043; PMCID: PMC4459618.

 

114: Tanaka H, Fujinami K, Watanabe K, Noda T, Akiyama K. Haptic breakage after

transscleral fixation of a single-piece acrylic intraocular lens. Case Rep

Ophthalmol. 2014 Jul 12;5(2):212-6. doi: 10.1159/000365350. PMID: 25126076;

PMCID: PMC4130822.

 

115: Yamazaki R, Tsunoda K, Fujinami K, Noda T, Tsubota K. Fundus

autofluorescence imaging in a patient with the juvenile form of

galactosialidosis. Ophthalmic Surg Lasers Imaging Retina. 2014 May-

Jun;45(3):259-61. doi: 10.3928/23258160-20140425-01. Epub 2014 Apr 29. PMID:

24779613.

 

116: Singh R, Fujinami K, Chen LL, Michaelides M, Moore AT. Longitudinal follow-

up of siblings with a discordant Stargardt disease phenotype. Acta Ophthalmol.

2014 Jun;92(4):e331-2. doi: 10.1111/aos.12280. Epub 2014 Jan 16. PMID: 24428930.

 

117: Fujinami K, Lois N, Mukherjee R, McBain VA, Tsunoda K, Tsubota K, Stone EM,

Fitzke FW, Bunce C, Moore AT, Webster AR, Michaelides M. A longitudinal study of

Stargardt disease: quantitative assessment of fundus autofluorescence,

progression, and genotype correlations. Invest Ophthalmol Vis Sci. 2013 Dec

17;54(13):8181-90. doi: 10.1167/iovs.13-12104. PMID: 24265018.

 

118: Nakamura N, Tsunoda K, Fujinami K, Shinoda K, Tomita K, Hatase T, Usui T,

Akahori M, Iwata T, Miyake Y. [Long-term observation over ten years of four

cases of cone dystrophy with supernormal rod electroretinogram]. Nippon Ganka

Gakkai Zasshi. 2013 Aug;117(8):629-40. Japanese. PMID: 24063160.

 

119: Fujinami K, Singh R, Carroll J, Zernant J, Allikmets R, Michaelides M,

Moore AT. Fine central macular dots associated with childhood-onset Stargardt

Disease. Acta Ophthalmol. 2014 Mar;92(2):e157-9. doi: 10.1111/aos.12259. Epub

2013 Sep 11. PMID: 24020726.

 

120: Fujinami K, Zernant J, Chana RK, Wright GA, Tsunoda K, Ozawa Y, Tsubota K,

Webster AR, Moore AT, Allikmets R, Michaelides M. ABCA4 gene screening by next-

generation sequencing in a British cohort. Invest Ophthalmol Vis Sci. 2013 Oct

11;54(10):6662-74. doi: 10.1167/iovs.13-12570. PMID: 23982839; PMCID:

PMC3796939.

 

121: Fujinami K, Sergouniotis PI, Davidson AE, Wright G, Chana RK, Tsunoda K,

Tsubota K, Egan CA, Robson AG, Moore AT, Holder GE, Michaelides M, Webster AR.

Clinical and molecular analysis of Stargardt disease with preserved foveal

structure and function. Am J Ophthalmol. 2013 Sep;156(3):487-501.e1. doi:

10.1016/j.ajo.2013.05.003. PMID: 23953153.

 

122: Fujinami K, Tsunoda K, Nakamura N, Kato Y, Noda T, Shinoda K, Tomita K,

Hatase T, Usui T, Akahori M, Itabashi T, Iwata T, Ozawa Y, Tsubota K, Miyake Y.

Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report

of novel disease-causing variants. Mol Vis. 2013 Jul 20;19:1580-90. PMID:

23885164; PMCID: PMC3718491.

 

123: Fujinami K, Sergouniotis PI, Davidson AE, Mackay DS, Tsunoda K, Tsubota K,

Robson AG, Holder GE, Moore AT, Michaelides M, Webster AR. The clinical effect

of homozygous ABCA4 alleles in 18 patients. Ophthalmology. 2013

Nov;120(11):2324-31. doi: 10.1016/j.ophtha.2013.04.016. Epub 2013 Jun 12. PMID:

23769331.

 

124: Fujinami K, Lois N, Davidson AE, Mackay DS, Hogg CR, Stone EM, Tsunoda K,

Tsubota K, Bunce C, Robson AG, Moore AT, Webster AR, Holder GE, Michaelides M. A

longitudinal study of stargardt disease: clinical and electrophysiologic

assessment, progression, and genotype correlations. Am J Ophthalmol. 2013

Jun;155(6):1075-1088.e13. doi: 10.1016/j.ajo.2013.01.018. Epub 2013 Mar 15.

PMID: 23499370.

 

125: Tsunoda K, Usui T, Hatase T, Yamai S, Fujinami K, Hanazono G, Shinoda K,

Ohde H, Akahori M, Iwata T, Miyake Y. Clinical characteristics of occult macular

dystrophy in family with mutation of RP1l1 gene. Retina. 2012 Jun;32(6):1135-47.

doi: 10.1097/IAE.0b013e318232c32e. PMID: 22466457.

 

126: Fujinami K, Tsunoda K, Nakamura M, Oguchi Y, Miyake Y. Oguchi disease with

unusual findings associated with a heterozygous mutation in the SAG gene. Arch

Ophthalmol. 2011 Oct;129(10):1375-6. doi: 10.1001/archophthalmol.2011.300. PMID:

21987685.

 

127: Chai Y, Yamazaki H, Fujinami K, Tsunoda K, Yamamoto S. Case of acute zonal

occult outer retinopathy with abnormal pattern visual evoked potentials. Clin

Ophthalmol. 2011;5:1235-41. doi: 10.2147/OPTH.S23194. Epub 2011 Sep 6. PMID:

21966193; PMCID: PMC3180490.

 

128: Tsunoda K, Fujinami K, Miyake Y. Selective abnormality of cone outer

segment tip line in acute zonal occult outer retinopathy as observed by

spectral-domain optical coherence tomography. Arch Ophthalmol. 2011

Aug;129(8):1099-101. doi: 10.1001/archophthalmol.2011.217. PMID: 21825201.

 

129: Fujinami K, Tsunoda K, Hanazono G, Shinoda K, Ohde H, Miyake Y. Fundus

autofluorescence in autosomal dominant occult macular dystrophy. Arch

Ophthalmol. 2011 May;129(5):597-602. doi: 10.1001/archophthalmol.2011.96. PMID:

21555613.

 

130: Fujinami K, Yokoi T, Hiraoka M, Nishina S, Azuma N. Choroidal

neovascularization in a child following laser pointer-induced macular injury.

Jpn J Ophthalmol. 2010 Nov;54(6):631-3. doi: 10.1007/s10384-010-0876-z. Epub

2010 Dec 30. PMID: 21191730.

 

131: Fujinami K, Akahori M, Fukui M, Tsunoda K, Iwata T, Miyake Y. Stargardt

disease with preserved central vision: identification of a putative novel

mutation in ATP-binding cassette transporter gene. Acta Ophthalmol. 2011

May;89(3):e297-8. doi: 10.1111/j.1755-3768.2009.01848.x. PMID: 20163366.

 

132: Terauchi N, Fujinami K, Shinoda K, Tsunoda K, Hanazono G, Miyake Y, Inomata

K. Transient macular dysfunction determined by focal macular electroretinogram.

Br J Ophthalmol. 2007 Dec;91(12):1709-10. doi: 10.1136/bjo.2006.113373. PMID:

18024815; PMCID: PMC2095554.

TEXTBOOK/BOOK CHAPTER

1.                  Fujinami-Yokokawa Y, Robson AG, Sergouniotis PI, Fujinaim K*. *Corresponding author. Ocult macular dystrophy. Clinical Ophthalmic Genetics and Genomics.2022:241-245

2.                  Fujinami K*, Fujinami-Yokokawa Y,* Yang L, Liu X, Arno G, Pontikos N; East Asia Inherited Retinal Disease Society(EAIRDs)Study Group. *Co-first authors. Stargardt Macular Dystrophy. Inherited Retinal Disease.2022:151-168

3.                  Liu X, Fujinami (Yokokawa) Y, Yang L, Arno G, Fujinami K*; East Asia Inherited Retinal Disease Consortium (EAIRDc). Stargardt disease in Asian population. Advances in Vision Research, Volume II, 2019. 279-295.

4.                  Georgiou M, Fujinami K, Michaelides M. Retinal Imaging in Inherited Retinal Diseases. Ann Eye Sci. 2020 Sep;5:25.

5.                  Fujinami K, Fujinami-Yokokawa Y, Yang L, Liu X, Arno G, Pontikos N; East Asia Inherited Retinal Disease Society (EAIRDs) Study Group. Stargardt disease. Inherited retinal disease, In Press.

MAJOR RESEARCH INTERESTS

  1. Electrophysiology

  2. Ophthalmic Genetics

  3. Vitreoretinal Surgery

  4. Artificial Intelligence

 

HOBBIES 

Music, travel, and swimming

 

Division for Vision Research, National Institute of Sensory Organs

© 2016 by Kaoru Fujinami. Proudly created with Wix.com

  • Facebook Clean Grey
  • Twitter Clean Grey
  • LinkedIn Clean Grey

UCL Institute of Ophthalmology associated with Moorfields Eye Hospital

bottom of page